<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1 20151215//EN" "https://jats.nlm.nih.gov/publishing/1.1/JATS-journalpublishing1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" specific-use="sps-1.9" dtd-version="1.1" xml:lang="pt" article-type="research-article">
  <front>
    <journal-meta>
      <journal-id journal-id-type="publisher-id">abc</journal-id>
      <journal-title-group>
        <journal-title>Arquivos Brasileiros de Cardiologia</journal-title>
        <abbrev-journal-title abbrev-type="publisher">Arq. Bras. Cardiol.</abbrev-journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0066-782X</issn>
      <issn pub-type="epub">1678-4170</issn>
      <publisher>
        <publisher-name>Sociedade Brasileira de Cardiologia - SBC</publisher-name>
        <publisher-loc>S&#227;o Paulo, SP, Brazil</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="publisher-id" specific-use="scielo-v3">fdXDkDXKC47hPJGBK3P9J4y</article-id>
      <article-id pub-id-type="other">00014</article-id>
      <article-id pub-id-type="publisher-id" specific-use="scielo-v2">S0066-782X2010000400014</article-id>
      <article-id pub-id-type="publisher-id" specific-use="scielo-v1">S0066-782X(10)09400414</article-id>
      <article-id pub-id-type="doi">10.1590/S0066-782X2010005000014</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Artigos Originais</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Preval&#234;ncia e fatores de risco para hipertens&#227;o em uma popula&#231;&#227;o urbana brasileira</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Cipullo</surname>
            <given-names>Jos&#233; Paulo</given-names>
          </name>
          <xref ref-type="aff" rid="aff01"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Martin</surname>
            <given-names>Jos&#233; Fernando Vilela</given-names>
          </name>
          <xref ref-type="aff" rid="aff01"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Ciorlia</surname>
            <given-names>Luiz Alberto de Souza</given-names>
          </name>
          <xref ref-type="aff" rid="aff01"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Godoy</surname>
            <given-names>Maria Regina Pereira de</given-names>
          </name>
          <xref ref-type="aff" rid="aff01"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Ca&#231;&#227;o</surname>
            <given-names>Jo&#227;o Castilho</given-names>
          </name>
          <xref ref-type="aff" rid="aff01"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Loureiro</surname>
            <given-names>Afonso Augusto Carvalho</given-names>
          </name>
          <xref ref-type="aff" rid="aff01"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Cesarino</surname>
            <given-names>Cl&#225;udia Bernardi</given-names>
          </name>
          <xref ref-type="aff" rid="aff01"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Carvalho</surname>
            <given-names>Ant&#244;nio C</given-names>
          </name>
          <xref ref-type="aff" rid="aff01"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Cordeiro</surname>
            <given-names>Jos&#233; Ant&#244;nio</given-names>
          </name>
          <xref ref-type="aff" rid="aff01"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Burdmann</surname>
            <given-names>Emmanuel de Almeida</given-names>
          </name>
          <xref ref-type="aff" rid="aff01"/>
        </contrib>
      </contrib-group>
      <aff id="aff01">
        <addr-line>
          <named-content content-type="state">S&#227;o Paulo</named-content>
        </addr-line>
        <institution content-type="orgname">Faculdade de Medicina de S&#227;o Jos&#233; do Rio Preto</institution>
        <country country="BR">Brazil</country>
      </aff>
      <pub-date date-type="collection" publication-format="electronic">
        <month>04</month>
        <year>2010</year>
      </pub-date>
      <volume>94</volume>
      <issue>4</issue>
      <fpage>519</fpage>
      <lpage>526</lpage>
      <history>
        <date date-type="received">
          <day>05</day>
          <month>01</month>
          <year>2009</year>
        </date>
        <date date-type="accepted">
          <day>25</day>
          <month>08</month>
          <year>2009</year>
        </date>
        <date date-type="rev-recd">
          <day>24</day>
          <month>05</month>
          <year>2009</year>
        </date>
      </history>
      <permissions>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/4.0/" xml:lang="en">
          <license-p>This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.</license-p>
        </license>
      </permissions>
      <abstract>
        <p>FUNDAMENTO: Os estudos dispon&#237;veis n&#227;o analisaram de modo abrangente os v&#225;rios fatores envolvidos na g&#234;nese da hipertens&#227;o (HT), especialmente a associa&#231;&#227;o entre press&#227;o arterial, excre&#231;&#227;o urin&#225;ria de s&#243;dio e disfun&#231;&#227;o renal. OBJETIVO: Avaliar a preval&#234;ncia dos fatores de risco para HT em diferentes grupos et&#225;rios em uma amostra representativa da uma popula&#231;&#227;o urbana brasileira. M&#201;TODOS: A popula&#231;&#227;o estudada (1.717 indiv&#237;duos adultos) foi avaliada por grupos et&#225;rios: 18 a 39 anos; 40 a 49; 50 a 59; 60 a 69 e &gt; 70 anos. As m&#233;dias das vari&#225;veis quantitativas e as vari&#225;veis categ&#243;ricas dos grupos normotenso e hipertenso foram comparadas. RESULTADOS: A preval&#234;ncia geral ajustada para HT foi de 25,23%. A preval&#234;ncia aumentou com a idade e era mais alta em indiv&#237;duos com baixo n&#237;vel educacional. &#205;ndice de massa corporal e circunfer&#234;ncia abdominal aumentados estavam positivamente associados com uma maior preval&#234;ncia de HT. Havia uma associa&#231;&#227;o positiva significante entre HT e excre&#231;&#227;o urinaria de s&#243;dio. Os indiv&#237;duos hipertensos apresentavam maior frequ&#234;ncia de disfun&#231;&#227;o renal, definida como clearance de creatinina &lt;60 ml/min/m&#178;. A preval&#234;ncia de diabetes mellitus na popula&#231;&#227;o geral era de 5,6% e 14,5% nos indiv&#237;duos hipertensos. A hipertens&#227;o era uma condi&#231;&#227;o conhecida por 74,4% dos indiv&#237;duos hipertensos. Entre os indiv&#237;duos hipertensos tratados, 52,4% tinham a hipertens&#227;o controlada e apenas 34,3% dos pacientes hipertensos no geral (tratados ou n&#227;o) tinham a press&#227;o arterial controlada. CONCLUS&#195;O: Esse estudo de base populacional &#233; especial devido ao fato de agregar diferentes fatores demogr&#225;ficos, epidemiol&#243;gicos e de risco envolvidos na g&#234;nese da hipertens&#227;o na avalia&#231;&#227;o de uma &#250;nica amostra com um c&#225;lculo populacional que pode ser extrapolado para outras popula&#231;&#245;es hipertensas.</p>
      </abstract>
      <kwd-group xml:lang="pt" kwd-group-type="author-generated">
        <kwd>Hipertens&#227;o</kwd>
        <kwd>epidemiologia e bioestat&#237;stica</kwd>
        <kwd>taxa de filtra&#231;&#227;o glomerular</kwd>
        <kwd>fatores de risco</kwd>
        <kwd>idade</kwd>
      </kwd-group>
      <pub-date publication-format="electronic" date-type="pub">
        <day>26</day>
        <month>03</month>
        <year>2010</year>
      </pub-date>
    </article-meta>
  </front>
  <body>
    <p>ARTIGO ORIGINAL </p>
    <p> HIPERTENS&#195;O ARTERIAL SIST&#202;MICA</p>
    <p>Preval&#234;ncia e fatores de risco para hipertens&#227;o em uma popula&#231;&#227;o urbana brasileira</p>
    <p>
      <bold>Jos&#233; Paulo Cipullo; Jos&#233; Fernando Vilela Martin; Luiz Alberto de Souza Ciorlia; Maria Regina Pereira de Godoy; Jo&#227;o Castilho Ca&#231;&#227;o; Afonso Augusto Carvalho Loureiro; Cl&#225;udia Bernardi Cesarino; Ant&#244;nio C Carvalho; Jos&#233; Ant&#244;nio Cordeiro; Emmanuel de Almeida Burdmann</bold>
    </p>
    <p> Faculdade de Medicina de S&#227;o Jos&#233; do Rio Preto/SP (FAMERP), S&#227;o Paulo, SP &#150; Brasil</p>
    <p>
      <xref ref-type="corresp" rid="nt">Correspond&#234;ncia</xref>
    </p>
    <p>
      <bold>RESUMO</bold>
    </p>
    <p><bold>FUNDAMENTO:</bold> Os estudos dispon&#237;veis n&#227;o analisaram de modo abrangente os v&#225;rios fatores envolvidos na g&#234;nese da hipertens&#227;o (HT), especialmente a associa&#231;&#227;o entre press&#227;o arterial, excre&#231;&#227;o urin&#225;ria de s&#243;dio e disfun&#231;&#227;o renal. </p>
    <p><bold>OBJETIVO:</bold> Avaliar a preval&#234;ncia dos fatores de risco para HT em diferentes grupos et&#225;rios em uma amostra representativa da uma popula&#231;&#227;o urbana brasileira. </p>
    <p><bold>M&#201;TODOS:</bold> A popula&#231;&#227;o estudada (1.717 indiv&#237;duos adultos) foi avaliada por grupos et&#225;rios: 18 a 39 anos; 40 a 49; 50 a 59; 60 a 69 e &gt; 70 anos. As m&#233;dias das vari&#225;veis quantitativas e as vari&#225;veis categ&#243;ricas dos grupos normotenso e hipertenso foram comparadas. </p>
    <p><bold>RESULTADOS:</bold> A preval&#234;ncia geral ajustada para HT foi de 25,23%. A preval&#234;ncia aumentou com a idade e era mais alta em indiv&#237;duos com baixo n&#237;vel educacional. &#205;ndice de massa corporal e circunfer&#234;ncia abdominal aumentados estavam positivamente associados com uma maior preval&#234;ncia de HT. Havia uma associa&#231;&#227;o positiva significante entre HT e excre&#231;&#227;o urinaria de s&#243;dio. Os indiv&#237;duos hipertensos apresentavam maior frequ&#234;ncia de disfun&#231;&#227;o renal, definida como clearance de creatinina &lt;60 ml/min/m<sup>2</sup>. A preval&#234;ncia de diabetes mellitus na popula&#231;&#227;o geral era de 5,6% e 14,5% nos indiv&#237;duos hipertensos. A hipertens&#227;o era uma condi&#231;&#227;o conhecida por 74,4% dos indiv&#237;duos hipertensos. Entre os indiv&#237;duos hipertensos tratados, 52,4% tinham a hipertens&#227;o controlada e apenas 34,3% dos pacientes hipertensos no geral (tratados ou n&#227;o) tinham a press&#227;o arterial controlada. </p>
    <p><bold>CONCLUS&#195;O: </bold>Esse estudo de base populacional &#233; especial devido ao fato de agregar diferentes fatores demogr&#225;ficos, epidemiol&#243;gicos e de risco envolvidos na g&#234;nese da hipertens&#227;o na avalia&#231;&#227;o de uma &#250;nica amostra com um c&#225;lculo populacional que pode ser extrapolado para outras popula&#231;&#245;es hipertensas. </p>
    <p><bold>Palavras-chave:</bold> Hipertens&#227;o, epidemiologia e bioestat&#237;stica, taxa de filtra&#231;&#227;o glomerular, fatores de risco, idade.</p>
    <p>
      <bold>Introdu&#231;&#227;o</bold>
    </p>
    <p>A doen&#231;a cardiovascular (DCV) &#233; a maior causa de mortalidade em pa&#237;ses desenvolvidos. No Brasil, a DCV &#233; respons&#225;vel por cerca de 30% da mortalidade geral e por 1,2 milh&#245;es de hospitaliza&#231;&#245;es, com um custo aproximado de 650 milh&#245;es de d&#243;lares/ano<sup>1,2</sup>. </p>
    <p>A hipertens&#227;o (HT) &#233; a mais prevalente de todas as DCV, afetando mais de 36 milh&#245;es de brasileiros adultos, sendo o maior fator de risco para les&#245;es card&#237;acas e cerebrovasculares e a terceira causa de invalidez<sup>1,2</sup>. A HT provavelmente est&#225; envolvida em 50% das mortes causadas por DCV<sup>3,4</sup>. O controle da press&#227;o arterial &#233; cr&#237;tico para a preven&#231;&#227;o de les&#227;o &#224; &#243;rg&#227;os induzida pela hipertens&#227;o, mas a natureza assintom&#225;tica dessa doen&#231;a faz com que ela seja sub-diagnosticada e consequentemente, sub-tratada, apesar de sua alta preval&#234;ncia. </p>
    <p>De fato, o<italic> National Health and Nutrition Examination Survey</italic> (NHANES) observou que 28,7% dos indiv&#237;duos avaliados eram hipertensos, 68,9% sabiam de sua condi&#231;&#227;o, 58,4% eram tratados e apenas 31% haviam atingido um controle efetivo da press&#227;o arterial<sup>5</sup>. </p>
    <p>No Brasil, a preval&#234;ncia de hipertens&#227;o e os fatores de risco associados t&#234;m sido avaliados desde o fim da d&#233;cada de 70, com uma ampla varia&#231;&#227;o entre os diferentes estudos. Essa disparidade provavelmente resulta da falta de padroniza&#231;&#227;o da metodologia e crit&#233;rios de sele&#231;&#227;o dos indiv&#237;duos analisados<sup>6-9</sup>. Outro poss&#237;vel fator &#233; a grande heterogeneidade entre diferentes regi&#245;es do pa&#237;s, com &#225;reas desenvolvidas e em desenvolvimento coexistindo. Al&#233;m disso, os estudos dispon&#237;veis n&#227;o analisaram completamente os v&#225;rios fatores envolvidos na g&#234;nese da hipertens&#227;o, especialmente a associa&#231;&#227;o entre a press&#227;o arterial, excre&#231;&#227;o urin&#225;ria de s&#243;dio e disfun&#231;&#227;o renal.</p>
    <p>O objetivo desse estudo foi avaliar a preval&#234;ncia de os fatores de risco para hipertens&#227;o em diferentes grupos et&#225;rios em uma amostra representativa de uma popula&#231;&#227;o urbana brasileira. </p>
    <p>
      <bold>M&#233;todos</bold>
    </p>
    <p>Esse projeto foi aprovado pelo Comit&#234; de &#201;tica em Pesquisas da Escola de Medicina de S&#227;o Jos&#233; do Rio Preto. Todos os participantes foram informados e instru&#237;dos sobre os resultados do teste e assinaram o termo de consentimento informado antes da sua inclus&#227;o no estudo. </p>
    <p>Em 2004 e 2005 um estudo transversal foi realizado em uma amostra representativa da popula&#231;&#227;o urbana adulta (<underline>&gt;</underline> 18 anos) em S&#227;o Jos&#233; do Rio Preto, estado de S&#227;o Paulo, Brasil. A amostra foi estratificada por idade de acordo com os dados do Instituto Brasileiro de Geografia e Estat&#237;stica (IBGE). Na &#233;poca da pesquisa, S&#227;o Jos&#233; do Rio Preto tinha uma popula&#231;&#227;o de cerca de 370.000 habitantes, com uma predomin&#226;ncia de indiv&#237;duos da ra&#231;a branca (82,8%) e uma distribui&#231;&#227;o equilibrada entre homens (48,4%) e mulheres (51,6%)<sup>10</sup>. Os grupos et&#225;rios avaliados foram: 18 a 39 anos; 40 a 49; 50 a 59; 60 a 69 e <underline>&gt;</underline> 70 anos. Os par&#226;metros usados para calcular os tamanhos de amostra das faixas et&#225;rias foram o n&#250;mero de habitantes, a preval&#234;ncia esperada de hipertens&#227;o para cada grupo et&#225;rio, m&#225;ximo permitido intervalo de confian&#231;a de 95%, semi-amplitude de 3%<sup>11</sup>. </p>
    <p>A cidade foi dividida nos setores censit&#225;rios utilizados pelo IBGE. Em cada setor, o n&#250;mero de indiv&#237;duos foi estudado de acordo com a proporcionalidade da popula&#231;&#227;o. Para cada regi&#227;o, ruas, resid&#234;ncias e um adulto que morava h&#225; mais de seis meses na resid&#234;ncia e que preenchia os crit&#233;rios de inclus&#227;o foram escolhidos ao acaso. Ap&#243;s a primeira resid&#234;ncia da rua ter sido escolhida, os entrevistadores atravessavam a rua e "pulavam" duas casas. Quando o indiv&#237;duo escolhido n&#227;o concordava em participar, um vizinho na casa ao lado era escolhido da mesma forma. Os crit&#233;rios de exclus&#227;o inclu&#237;am gravidez, doen&#231;as psiqui&#225;tricas graves ou incapacidade mental e indiv&#237;duos confinados ao leito. </p>
    <p>Os entrevistadores foram previamente treinados e monitorados por um coordenador de campo. Os participantes responderam um question&#225;rio que inclu&#237;a dados pessoais, renda e propriedades para avaliar o n&#237;vel socioecon&#244;mico, n&#237;vel de escolaridade, hist&#243;rico m&#233;dico pessoal e familiar, conhecimento da hipertens&#227;o e medicamentos sendo utilizados. </p>
    <p>Depois disso, os m&#233;dicos verificaram as entrevistas e mediram a press&#227;o arterial (PA), frequ&#234;ncia card&#237;aca (FC) e dados antropom&#233;tricos. Os participantes foram instru&#237;dos a fazer jejum durante a noite e coletar urina de 12 horas para os testes bioqu&#237;micos. No dia seguinte &#224; primeira visita, a urina coletada foi recolhida e uma amostra de sangue foi coletada em jejum. </p>
    <p>A t&#233;cnica de mensura&#231;&#227;o da PA foi aquela padronizada pelo <italic>VII Joint National Committee</italic><sup>12</sup>: 1) as medidas foram feitas com um esfigmoman&#244;metro aner&#243;ide recentemente calibrado cuja precis&#227;o era conhecida; 2) o manguito foi posicionado de forma que a borda inferior ficasse 3 cm acima da prega do cotovelo e a bra&#231;adeira foi centralizada sobre a art&#233;ria braquial; 3) foi utilizada uma bra&#231;adeira padr&#227;o (12&#150;13 cm de comprimento e 35 cm de largura), mas bra&#231;adeiras maiores e menores estavam dispon&#237;veis, para bra&#231;os mais grossos ou mais finos, respectivamente; 4) o bra&#231;o estava nu e estava apoiado com o manguito de press&#227;o arterial a n&#237;vel do cora&#231;&#227;o; 5) a m&#233;dia de tr&#234;s medidas de PA na posi&#231;&#227;o sentada ap&#243;s 5 a 10 minutos de descanso foi utilizada; 6) as fases I e V (desaparecimento) dos sons de Korotkoff foram registrados para identificar a PA sist&#243;lica e diast&#243;lica, respectivamente; 7) a press&#227;o foi aumentada rapidamente para 30 mmHg acima do n&#237;vel no qual o pulso radial era extinto; 8) uma taxa de defla&#231;&#227;o do manguito de 2 mmHg por batimento foi utilizada; 9) foi recomendado um intervalo de pelo menos 1 minuto entre as leituras a fim de evitar congest&#227;o venosa; 10) a PA foi medida em ambos os bra&#231;os para detectar poss&#237;veis diferen&#231;as devido &#224; doen&#231;a vascular perif&#233;rica; nesse caso, o maior valor foi tomado como refer&#234;ncia. A hipertens&#227;o foi definida como PA sist&#243;lica <underline>&gt;</underline> 140 mmHg e/ou PA diast&#243;lica <underline>&gt;</underline> 90 mmHg ou uso corrente de medicamentos anti-hipertensivos. Os indiv&#237;duos foram classificados como pacientes normotensos (N), pacientes com hipertens&#227;o desconhecida, com hipertens&#227;o tratada e controlada e com hipertens&#227;o tratada e n&#227;o-controlada. Para os indiv&#237;duos com valores lim&#237;trofes de PA, uma nova medida foi obtida em um dia diferente no mesmo hor&#225;rio da &#250;ltima medi&#231;&#227;o. </p>
    <p>O n&#237;vel socioecon&#244;mico foi classificado em A, B, C, D ou E (baseado na renda familiar e propriedades, com A e B sendo os n&#237;veis mais altos). Os n&#237;veis A e B foram considerados de acordo com a renda familiar acima de 10 sal&#225;rios m&#237;nimos, o n&#237;vel C entre 3 e 5 sal&#225;rios m&#237;nimos e os n&#237;veis D/E abaixo de 3 sal&#225;rios m&#237;nimos. O n&#237;vel de escolaridade foi definido pelo n&#250;mero de anos de estudo e a amostra foi dividida em 3 grupos: E<sub>1</sub> at&#233; 7 anos de escolaridade, E<sub>2</sub> 8 a 10 anos de escolaridade e E<sub>3</sub><underline>&gt;</underline> 11 anos de escolaridade, incluindo a educa&#231;&#227;o universit&#225;ria<sup>13</sup>. </p>
    <p>O &#237;ndice de massa corporal (IMC) foi obtido pela raz&#227;o peso/altura<sup>2</sup> (kg/m<sup>2</sup>). O exame foi realizado com os indiv&#237;duos com os p&#233;s descal&#231;os, vestindo roupas leves. Uma balan&#231;a port&#225;til calibrada foi utilizada para a medida do peso. A altura e a circunfer&#234;ncia abdominal (CA) foram medidos em cent&#237;metros usando-se uma fita m&#233;trica. A medida da CA foi realizada utilizando-se a metade da dist&#226;ncia entre a crista il&#237;aca superior anterior e a ultima costela, no final da expira&#231;&#227;o. O IMC classificou os indiv&#237;duos como normal (&lt; 25), sobrepeso (25 a 29,9) ou obeso (<underline>&gt;</underline> 30 kg/m<sup>2</sup>) (<xref ref-type="table" rid="tab01">Tabela 1</xref>)<sup>14,15</sup>. A varia&#231;&#227;o normal da CA foi a utilizada pelo <italic>National Cholesterol Education Program</italic> - ATPIII<sup>16</sup> e os indiv&#237;duos foram divididos em 3 grupos (<xref ref-type="table" rid="tab01">Tabela 1</xref>). </p>
    <table-wrap id="tab01">
      <graphic xlink:href="1678-4170-abc-94-04-0519-00014-gt01.jpg"/></table-wrap>
    <p>O s&#243;dio urin&#225;rio (mEq/L) foi avaliado por fotometria de chama. A excre&#231;&#227;o do s&#243;dio urin&#225;rio foi calculada pela multiplica&#231;&#227;o da concentra&#231;&#227;o do s&#243;dio urin&#225;rio em mEq/L pelo volume urin&#225;rio de 12 horas<sup>17</sup> e os participantes foram divididos em: grupo Na<sup>+</sup> I com s&#243;dio urin&#225;rio &lt; 100 mEq/12h, grupo Na<sup>+</sup> II com s&#243;dio urin&#225;rio &gt; 100 e &lt; 150 mEq/12h e grupo Na<sup>+</sup> III com s&#243;dio urin&#225;rio <underline>&gt;</underline> 150 mEq/12h. O volume urin&#225;rio de 12 horas e as concentra&#231;&#245;es de creatinina urin&#225;ria e no plasma foram avaliados para calcular o clearance de creatinina ajustado para superf&#237;cie corp&#243;rea.</p>
    <p>O diagn&#243;stico de <italic>diabetes mellitus</italic> (DM) foi estabelecido pelo hist&#243;rico, uso de medicamentos hipoglicemiantes e medida de glicose s&#233;rica<sup>18</sup>. O m&#233;todo colorim&#233;trico, o dispositivo Dimension RXL e o reagente Dade Behring foram usados para as medidas de glicemia e creatinina. A <xref ref-type="table" rid="tab01">Tabela 1</xref> mostra a varia&#231;&#227;o categ&#243;rica para os testes bioqu&#237;micos.</p>
    <p>
      <bold>An&#225;lise estat&#237;stica</bold>
    </p>
    <p>A an&#225;lise estat&#237;stica foi realizada utilizando-se o programa Minitab vers&#227;o 12.22 e R 2.4.1<sup>19,20</sup>. Para cada grupo et&#225;rio, as m&#233;dias das vari&#225;veis quantitativas foram calculadas e os grupos normotenso e hipertenso foram comparados pelo Teste <italic>t</italic> de <italic>Student</italic>. As vari&#225;veis categ&#243;ricas (obesidade, sexo, escolaridade, etc.) e o controle da PA foram estimadas pelo teste qui-quadrado de Pearson ou teste exato de Fisher. As associa&#231;&#245;es da hipertens&#227;o e PA normal com as mesmas vari&#225;veis categ&#243;ricas, de acordo com o grupo et&#225;rio, foram avaliadas pelo teste da raz&#227;o de verossimilhan&#231;a para amostras independentes. Como as amostras foram estratificadas de acordo com o grupo et&#225;rio, por causa da an&#225;lise, a popula&#231;&#227;o total deve ser considerada como uma mistura de sub-popula&#231;&#245;es, os grupos et&#225;rios: 18 a 39 anos, 40 a 49, 50 a 59, 60 a 69, <underline>&gt;</underline> 70 anos, respectivamente ponderados por 0,5533; 0,1855; 0,1229; 0,0820 e 0,0573. Assim, qualquer propor&#231;&#227;o a ser avaliada na popula&#231;&#227;o &#233; uma combina&#231;&#227;o convexa da propor&#231;&#227;o das faixas, cujos estimadores s&#227;o independentes uns dos outros. </p>
    <p> A avalia&#231;&#227;o das estruturas de associa&#231;&#227;o da PA com qualquer outra vari&#225;vel da popula&#231;&#227;o foi realizada pela aproxima&#231;&#227;o multinormal com a combina&#231;&#227;o convexa, ponderada com pesos acima, de distribui&#231;&#245;es multinormais para as frequ&#234;ncias das amostras nos extratos. A preval&#234;ncia e <italic>odds ratios (OR)</italic> foram analisados atrav&#233;s de transforma&#231;&#245;es lineares do logaritmo natural das freq&#252;&#234;ncias relativas combinadas<sup>21</sup>.</p>
    <p>
      <bold>Resultados</bold>
    </p>
    <p>Cinco por cento dos indiv&#237;duos sorteados n&#227;o aceitaram participar do estudo e um grupo de 1.717 adultos, com idade variando de 18 a 93 anos (55,0 &#177; 14,7 anos); 838 homens (48,8%, 55,1 &#177; 14,9 anos) e 879 mulheres (51,2%, 55,0 &#177; 14,4 anos) foram estudados. </p>
    <p>Da amostra total, 762 indiv&#237;duos eram hipertensos. A preval&#234;ncia estimada e ajustada da hipertens&#227;o para essa popula&#231;&#227;o foi de 25,23% (IC95% [21,4, 30,0]). A idade do grupo hipertenso ajustada para a popula&#231;&#227;o da cidade foi 44,9 anos (IC95% [43,9, 45,6]) para mulheres e 42,4 (IC95% [40,8, 43,9]) para homens. A idade do grupo normotenso ajustada para a popula&#231;&#227;o foi de 43,7 anos (IC95% [43,2, 44,4]) para mulheres e 50,0 (IC95% [49,4, 50,8]) para homens.</p>
    <p>A preval&#234;ncia da hipertens&#227;o aumentou progressivamente e significantemente com a idade at&#233; os 69 anos (p&lt;0,001). Nenhuma diferen&#231;a foi observada entre os grupos com 60 a 69 anos e <underline>&gt;</underline> 70 anos de idade (ver <xref ref-type="table" rid="tab02">Tabela 2</xref>).</p>
    <table-wrap id="tab02">
      <graphic xlink:href="1678-4170-abc-94-04-0519-00014-gt02.jpg"/></table-wrap>
    <p>A preval&#234;ncia da hipertens&#227;o foi similar em mulheres (26,8%) e homens (23,8%), exceto no grupo et&#225;rio <underline>&gt;</underline> 70 anos, com uma maior preval&#234;ncia entre mulheres (82,4%) quando comparadas aos homens (57,1%, p&lt;0,05).</p>
    <p>A popula&#231;&#227;o estudada inclu&#237;a 79,6% de indiv&#237;duos brancos e 20,4% de indiv&#237;duos n&#227;o-brancos, com uma preval&#234;ncia de hipertens&#227;o de 25,0% e 26,9%, respectivamente (<xref ref-type="table" rid="tab03">Tabela 3</xref>).</p>
    <table-wrap id="tab03">
      <graphic xlink:href="1678-4170-abc-94-04-0519-00014-gt03.jpg"/></table-wrap>
    <p>Em rela&#231;&#227;o ao n&#237;vel de escolaridade, a seguinte distribui&#231;&#227;o populacional foi observada: E<sub>1</sub> 44,6% (IC95%, 41,0-48,2); E<sub>2</sub> 16,1% (IC95%, 13,1-19,2) e E<sub>3</sub> 39,3% (IC95%, 35,5-43,1). A preval&#234;ncia de hipertens&#227;o foi maior no grupo E<sub>1</sub> quando comparado com os outros dois grupos (p&lt;0,005), e nenhuma diferen&#231;a foi observada entre os grupos E<sub>2</sub> e E<sub>3</sub> (<xref ref-type="table" rid="tab03">Tabela 3</xref>).</p>
    <p>Os n&#237;veis socioecon&#244;micos foram agrupados em AB, C e DE. As estimativas de n&#237;vel socioecon&#244;mico para a popula&#231;&#227;o adulta foram: AB 19,8% (IC95%, 17,0-22,7); C 43,2% (IC95%, 39,4-47,0) e DE 37% (IC95%, 33,2-40,7). A preval&#234;ncia estimada da hipertens&#227;o foi similar em todos os n&#237;veis sociais, exceto pelo n&#237;vel DE comparado ao C (<xref ref-type="table" rid="tab03">Tabela 3</xref>).</p>
    <p>Um hist&#243;rico familiar positivo de hipertens&#227;o foi observado no grupo hipertenso quando comparado ao grupo normotenso para indiv&#237;duos com idade <underline>&gt;</underline> 50 anos (p&lt;0,05), com hist&#243;rico familiar positivo para hipertens&#227;o no grupo et&#225;rio de 60 a 69 anos atingindo uma preval&#234;ncia de 75,1% (p=0,001 comparado a 23,9% nos indiv&#237;duos normotensos). </p>
    <p>O IMC era normal em 44,6% da popula&#231;&#227;o estudada; 33,2% tinham sobrepeso e 22,2% eram obesos, isto &#233;, 55,4% tinham IMC acima do normal. Uma maior preval&#234;ncia de hipertens&#227;o foi observada em todos os grupos et&#225;rios para indiv&#237;duos com sobrepeso e obesos, quando comparados &#224;queles com IMC normal (p&lt;0,001) (<xref ref-type="table" rid="tab03">Tabela 3</xref>). A preval&#234;ncia de hipertens&#227;o aumentou progressivamente de acordo com o aumento da CA em todos os grupos et&#225;rios (p&lt;0,0005). </p>
    <p>A preval&#234;ncia estimada de diabetes foi 5,6% (IC95%, 4,5-6,7) na popula&#231;&#227;o em geral, 14,5% (IC95%, 12,7-17,4) em indiv&#237;duos hipertensos e 2,5% (IC95%, 2,1-3,0) em indiv&#237;duos normotensos (p&lt;0,0005). Houve uma clara associa&#231;&#227;o entre diabetes e hipertens&#227;o (p&lt;0,05) em todos os grupos et&#225;rios &gt; 50 anos. Quando os grupos hipertenso e normotenso foram comparados em rela&#231;&#227;o &#224; presen&#231;a de <italic>diabetes mellitus</italic>, um OR de 6,54 (IC95%, 3,73-11,42; p&lt;0,0005) foi observado.</p>
    <p>A preval&#234;ncia estimada de hipertens&#227;o foi de 21,6% para o grupo Na<sup>+</sup> I (IC95%, 17,9-26,1), 28,8% para o grupo Na<sup>+</sup> II (IC95%, 22,8-36,3) e 32,8% para o grupo Na<sup>+</sup> III (IC95%, 25,5-42,2), com uma maior preval&#234;ncia de hipertens&#227;o no grupo Na<sup>+</sup> II quando comparado ao grupo Na<sup>+ </sup>I (p = 0,03) e no grupo Na<sup>+ </sup>III comparado ao grupo Na<sup>+ </sup>I (p = 0,006). N&#227;o houve diferen&#231;as na preval&#234;ncia de hipertens&#227;o entre os grupos Na<sup>+</sup> II e Na<sup>+</sup> III. A presen&#231;a de s&#243;dio urin&#225;rio <underline>&gt;</underline> 150 mEq/l foi mais frequente nos indiv&#237;duos hipertensos do que nos indiv&#237;duos normotensos com risco de hipertens&#227;o 76% maior com esse n&#237;vel de excre&#231;&#227;o de s&#243;dio (<xref ref-type="table" rid="tab04">Tabela 4</xref>). </p>
    <table-wrap id="tab04">
      <graphic xlink:href="1678-4170-abc-94-04-0519-00014-gt04.jpg"/></table-wrap>
    <p>O clearance de creatinina (ClCr) foi analisado em 1.306 indiv&#237;duos. Valores &lt; 60 ml/min/m<sup>2</sup> foram observados em 5,4% dos indiv&#237;duos normotensos e 20,8% dos indiv&#237;duos hipertensos (<xref ref-type="table" rid="tab04">Tabela 4</xref>). Quando os indiv&#237;duos hipertensos e normotensos foram comparados, foi observado que 295 (96,4%) daqueles com ClCr &lt;60 ml/min/m<sup>2</sup> tinham <underline>&gt;</underline> 50 anos de idade. </p>
    <p>A hipertens&#227;o era uma condi&#231;&#227;o conhecida por 74,4% (IC95%, 71,3-77,5) dos indiv&#237;duos hipertensos e era desconhecida por 25,6% (IC95%, 22,5-28,7). Entre os indiv&#237;duos hipertensos tratados, 52,4% (IC95%, 48,2-56,6) tinham PA controlada. Entre todos os indiv&#237;duos hipertensos (tratados ou n&#227;o) apenas 34,3% tinham a PA controlada.</p>
    <p>
      <bold>Discuss&#227;o</bold>
    </p>
    <p>A preval&#234;ncia da hipertens&#227;o &#233; maior em pa&#237;ses desenvolvidos do que em pa&#237;ses em desenvolvimento, mas a grande massa populacional em pa&#237;ses em desenvolvimento tem contribu&#237;do de forma significante para o n&#250;mero total de indiv&#237;duos hipertensos no mundo todo. Estima-se que por volta de 2025, 1,5 bilh&#245;es de pessoas ser&#227;o hipertensos<sup>22</sup>. Atualmente, a preval&#234;ncia m&#233;dia mundial estimada da hipertens&#227;o &#233; de 26,4%, com uma ampla varia&#231;&#227;o dependendo da popula&#231;&#227;o estudada, atingindo 21,0% nos EUA e Canad&#225;, 33,5 a 39,7% nos pa&#237;ses europeus, 15 a 21,7% nos pa&#237;ses africanos e asi&#225;ticos e cerca de 40% na Am&#233;rica Latina<sup>22-24</sup>.</p>
    <p>A preval&#234;ncia da hipertens&#227;o no Brasil varia de 24,8 a 44,4%<sup>6-9</sup>. No presente estudo, a preval&#234;ncia de hipertens&#227;o foi avaliada de acordo com grupos et&#225;rios, determinando um n&#250;mero de indiv&#237;duos proporcional ao n&#250;mero de habitantes para cada grupo et&#225;rio e ajustando-os para a popula&#231;&#227;o adulta. Essa caracter&#237;stica do presente estudo &#233; distinta da maioria dos estudos anteriores, os quais inclu&#237;ram um n&#250;mero expressivo de mulheres e idosos. Alem disso, poucos estudos anteriores avaliaram simultaneamente os fatores de risco mais importantes para a hipertens&#227;o na mesma popula&#231;&#227;o. A preval&#234;ncia estimada de hipertens&#227;o na popula&#231;&#227;o estudada foi de 25,3% e um aumento progressivo foi observado com a idade, chegando a 70% entre os indiv&#237;duos com mais de 70 anos. Com o prop&#243;sito de compara&#231;&#227;o, os grupos et&#225;rios foram re-agrupados utilizando-se crit&#233;rios similares &#224;queles adotados pelo estudo NHANES 2003-2004<sup>25 </sup>e o teste c<sup>2</sup> foi aplicado e resultados similares foram obtidos (<xref ref-type="table" rid="tab05">Tabela 5</xref>). O evidente aumento na preval&#234;ncia da hipertens&#227;o ap&#243;s os 40 anos de idade e o potencial de manejo dos fatores de risco modific&#225;veis para hipertens&#227;o ap&#243;iam a ado&#231;&#227;o imediata de medidas preventivas e educacionais representando um importante investimento em sa&#250;de p&#250;blica.</p>
    <table-wrap id="tab05">
      <graphic xlink:href="1678-4170-abc-94-04-0519-00014-gt05.jpg"/></table-wrap>
    <p>A preval&#234;ncia de hipertens&#227;o n&#227;o foi diferente entre os sexos, mesmo quando a popula&#231;&#227;o foi estratificada em diferentes grupos et&#225;rios, exceto para mulheres com idade <underline>&gt;</underline> 70 anos, o que tamb&#233;m foi demonstrado por outros autores<sup>26</sup>. </p>
    <p>N&#227;o houve diferen&#231;as significantes na preval&#234;ncia de hipertens&#227;o entre os diversos grupos &#233;tnicos na popula&#231;&#227;o estudada, embora estudos norte-americanos tenham relatado uma maior preval&#234;ncia e gravidade de hipertens&#227;o em indiv&#237;duos negros. &#201; poss&#237;vel que o maior n&#250;mero de indiv&#237;duos brancos na popula&#231;&#227;o atual ou o maior grau de miscigena&#231;&#227;o no Brasil tenham influenciado os resultados obtidos<sup>27</sup>.</p>
    <p>As diferen&#231;as socioecon&#244;micas t&#234;m um papel importante nas condi&#231;&#245;es de sa&#250;de que influenciam diferentes fatores, tais como acesso ao sistema de sa&#250;de, grau de informa&#231;&#227;o, entendimento da condi&#231;&#227;o m&#233;dica e ader&#234;ncia ao tratamento<sup>28</sup>. Diferentes estudos mostraram taxas mais altas de DCV em grupos com n&#237;vel socioecon&#244;mico mais baixo<sup>29</sup>. Entretanto, n&#227;o houve diferen&#231;a significante na preval&#234;ncia da hipertens&#227;o relacionada ao n&#237;vel socioecon&#244;mico no presente estudo, apesar de uma tend&#234;ncia &#224; maior preval&#234;ncia nas classes C e D/E. &#201; poss&#237;vel que essa seja uma caracter&#237;stica distinta de pa&#237;ses em desenvolvimento. Indiv&#237;duos com n&#237;vel de escolaridade mais baixo apresentaram uma maior preval&#234;ncia de hipertens&#227;o em todos os grupos et&#225;rios. Quando o OR foi comparado, usando-se o n&#237;vel de escolaridade mais alto como refer&#234;ncia, o risco de hipertens&#227;o foi 2,8 vezes maior para aqueles com n&#237;vel de escolaridade mais baixo, o que tamb&#233;m foi observado no NHANES, que mostrou um OR de 1,14 (IC95%, 1,01 a 1,97) para preval&#234;ncia de hipertens&#227;o no grupo com n&#237;vel de escolaridade mais baixo<sup>25</sup>. </p>
    <p>N&#227;o houve diferen&#231;a significante entre indiv&#237;duos normotensos e hipertensos em rela&#231;&#227;o ao hist&#243;rico familiar para os grupos et&#225;rios at&#233; 49 anos. Entretanto, ap&#243;s 50 anos de idade, houve uma maior preval&#234;ncia de hist&#243;rico familiar positivo em indiv&#237;duos hipertensos, o que pode explicar as diferen&#231;as observadas<sup>30,31</sup>.</p>
    <p>Foi observada uma rela&#231;&#227;o linear em todos os grupos et&#225;rios entre o IMC e a PA, bem como com a CA. Sobrepeso e obesidade s&#227;o fatores de risco reais para hipertens&#227;o, pois indiv&#237;duos nesses grupos et&#225;rios apresentavam um aumento de 2 e 3,6 vezes o risco de ter hipertens&#227;o, respectivamente. Tamb&#233;m havia uma rela&#231;&#227;o proporcional entre a preval&#234;ncia da hipertens&#227;o e o aumento da CA. De fato, a CA e o IMC s&#227;o considerados bons preditores do risco de desenvolver hipertens&#227;o<sup>32-34</sup>. No presente estudo, o risco de hipertens&#227;o estava mais relacionado &#224; obesidade definida pela maior CA, do que o IMC maior, como observado por outros autores<sup>34. </sup></p>
    <p>A preval&#234;ncia da DM foi maior em indiv&#237;duos hipertensos, com um OR de 6,54, o que carrega uma carga adicional para doen&#231;a cardiovascular. &#201; poss&#237;vel que o dano endotelial promovido pela DM tenha contribu&#237;do para o desenvolvimento da hipertens&#227;o nessa popula&#231;&#227;o. A preval&#234;ncia de diabetes na popula&#231;&#227;o norte-americana &#233; de aproximadamente 7% e 30% deles desconhecem sua condi&#231;&#227;o. A preval&#234;ncia de DM aumenta com a idade, chegando a 20% em indiv&#237;duos com idade <underline>&gt;</underline>60 anos<sup>35</sup>, o que foi similar &#224; taxa de 22% observada nesse grupo et&#225;rio do presente estudo (dados n&#227;o informados).</p>
    <p>A excre&#231;&#227;o urinaria de s&#243;dio apresentou uma correla&#231;&#227;o positiva e significante com os n&#237;veis de PA em todos os grupos et&#225;rios. Esses achados, raramente descritos em estudos de preval&#234;ncia de hipertens&#227;o, indicam uma associa&#231;&#227;o positiva entre o consumo de sal, excre&#231;&#227;o de s&#243;dio urin&#225;rio e a preval&#234;ncia de hipertens&#227;o<sup>36,37</sup>.</p>
    <p>A disfun&#231;&#227;o renal, avaliada atrav&#233;s do clearance de creatinina &lt; 60/ml/min, foi mais prevalente entre indiv&#237;duos hipertensos. De fato, indiv&#237;duos hipertensos apresentavam um risco 4,5 vezes maior de disfun&#231;&#227;o renal, especialmente ap&#243;s os 50 anos de idade. Esse achado sugere uma poss&#237;vel associa&#231;&#227;o entre hipertens&#227;o e disfun&#231;&#227;o renal, independente da idade. </p>
    <p>Estudos populacionais t&#234;m mostrado diversos graus de conhecimento da hipertens&#227;o por indiv&#237;duos hipertensos. Nos pa&#237;ses europeus, esses n&#237;veis variam de 52,7% na Alemanha a 70% na Su&#233;cia. Na Am&#233;rica do Norte, a taxa de conhecimento &#233; de 82,1% nos EUA. A taxa de controle da PA na popula&#231;&#227;o hipertensiva em geral tamb&#233;m varia. Na Europa as taxas variam de 22,9% na Espanha a 37,7% na Inglaterra. No presente estudo o grau de conhecimento da hipertens&#227;o era alto e similar &#224;queles encontrados pelo estudo NHANES. No presente estudo, entre os indiv&#237;duos hipertensos tratados, cerca de 50% tinham a PA controlada e cerca de 30% dos pacientes hipertensos em geral tinham a PA controlada. Esses dados tamb&#233;m s&#227;o similares aos do estudo NHANES 2003-2004, que mostrou que a taxa de controle ajustada pela idade era de 63,9% para indiv&#237;duos hipertensos tratados e 33,1% para os pacientes hipertensos em geral<sup>25</sup>. Esses resultados favor&#225;veis s&#227;o provavelmente devido &#224;s informa&#231;&#245;es adequadas dadas ao p&#250;blico sobre a doen&#231;a, investimento no treinamento de profissionais da sa&#250;de, participa&#231;&#227;o de equipes multidisciplinares no sistema de sa&#250;de local, disponibilidade de medicamentos anti-hipertensivos fornecidos pelo governo sem custo e uma pol&#237;tica mais agressiva no n&#237;vel de cuidados prim&#225;rios, como observado em outros pa&#237;ses em desenvolvimento<sup>38</sup>.</p>
    <p>Algumas limita&#231;&#245;es do presente estudo devem ser mencionadas. Primeiro, as diretrizes da <italic>American Diabetes Association</italic> recomendam a confirma&#231;&#227;o da hiperglicemia em uma segunda medida, o que n&#227;o foi feito neste estudo. Por outro lado, os estudos epidemiol&#243;gicos, entre eles o NHANES, utilizam quase exclusivamente uma &#250;nica medida de glicose no sangue para o diagn&#243;stico de DM. Segundo, o consumo de sal foi baseado em uma &#250;nica medida de excre&#231;&#227;o de s&#243;dio, o que tamb&#233;m verdadeiro para a avalia&#231;&#227;o da filtra&#231;&#227;o glomerular atrav&#233;s de uma &#250;nica medida de clearance de creatinina. No presente estudo, tamb&#233;m n&#227;o estudamos o perfil lip&#237;dico, um fato que n&#227;o nos permite avaliar a dimens&#227;o das altera&#231;&#245;es metab&#243;licas associadas com a hipertens&#227;o.</p>
    <p>Por outro lado, esse estudo de base populacional, com um grupo controle normotenso, &#233; especial pelo fato de agregar diferentes fatores demogr&#225;ficos, epidemiol&#243;gicos e de risco envolvidos na g&#234;nese da hipertens&#227;o e das DCV na avalia&#231;&#227;o de uma &#250;nica amostra, com um calculo populacional que pode ser extrapolado para outras popula&#231;&#245;es hipertensas.</p>
    <p>
      <bold>Agradecimentos</bold>
    </p>
    <p>Agradecemos &#224; Livia C. Burdmann pela cuidadosa revis&#227;o gramatical do manuscrito. Tamb&#233;m gostar&#237;amos de agradecer &#224; Carla G. R. Carvalho, Lina Galli e Rosemara S. Machado por sua ajuda com as entrevistas. Por fim, gostar&#237;amos de agradecer a ajuda de Elisabeth R. R. Zago e Fernanda R. Campos. Dr. Emmanuel A. Burdmann tem apoio financeiro parcial do CNPq.</p>
    <p>
      <bold>Potencial Conflito de Interesses</bold>
    </p>
    <p>Declaro n&#227;o haver conflito de interesses pertinentes.</p>
    <p>
      <bold>Fontes de Financiamento</bold>
    </p>
    <p>O presente estudo n&#227;o teve fontes de financiamento externas.</p>
    <p>
      <bold>Vincula&#231;&#227;o Acad&#234;mica</bold>
    </p>
    <p>N&#227;o h&#225; vincula&#231;&#227;o deste estudo a programas de p&#243;s-gradua&#231;&#227;o.</p>
    <p>
      <fn id="nt" fn-type="corresp">
        <p>Correspond&#234;ncia:</p>
        <p>Jos&#233; Fernando Vilela Martin </p>
        <p> Av. Anisio Haddad, 7700 casa 129 - Jardim das Palmeiras </p>
        <p> 15093-000 - S&#227;o Jos&#233; do Rio Preto, SP - Brasil </p>
        <p> E-mail: </p>
        <p><email xlink:href="vilelamartin@cardiol.br">vilelamartin@cardiol.br</email>, </p>
        <p>
          <email xlink:href="vilelamartin@uol.com.br">vilelamartin@uol.com.br</email>
        </p>
      </fn>
    </p>
    <p>Artigo recebido em 05/01/09; revisado recebido em 24/05/09; aceito em 25/08/09.</p>
  </body>
  <back>
    <ref-list>
      <ref id="B1">
        <mixed-citation>1. Minist&#233;rio da Sa&#250;de. DATASUS. Information about health: mortality. [Accessed 2007 July 02]. Available at: <ext-link ext-link-type="uri" xlink:href="http://tabnet.datasus.gov.br/cgi/tabcgi.exe?sim/cnv/obtuf.def">http://tabnet.datasus.gov.br/cgi/tabcgi.exe?sim/cnv/obtuf.def</ext-link></mixed-citation>
        <element-citation publication-type="book">
          <source>Information about health: mortality</source>
        </element-citation>
      </ref>
      <ref id="B2">
        <mixed-citation>2. Minist&#233;rio da Sa&#250;de. DATASUS. Information about health: morbidity. [Accessed 2007 July 02]. Available at: <ext-link ext-link-type="uri" xlink:href="http://tabnet.datasus.gov.br/cgi/tabcgi.exe?sih/cnv/miuf.def">http://tabnet.datasus.gov.br/cgi/tabcgi.exe?sih/cnv/miuf.def</ext-link></mixed-citation>
        <element-citation publication-type="book">
          <source>Information about health: morbidity</source>
        </element-citation>
      </ref>
      <ref id="B3">
        <mixed-citation>3. Bronner LL, Kanter DS, Manson JE. Primary prevention of stroke. N Engl J Med. 1995; 333: 1392-400.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Primary prevention of stroke</article-title>
          <source>N Engl J Med</source>
          <date>
            <year>1995</year>
          </date>
          <fpage>1392</fpage>
          <lpage>400</lpage>
          <volume>333</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Bronner</surname>
              <given-names>LL</given-names>
            </name>
            <name>
              <surname>Kanter</surname>
              <given-names>DS</given-names>
            </name>
            <name>
              <surname>Manson</surname>
              <given-names>JE</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B4">
        <mixed-citation>4. He J, Whelton PK. Elevated systolic blood pressure and risk of cardiovascular and renal disease: overview of evidence from observational epidemiologic studies and randomized controlled trials. Am Heart J. 1999; 138: 211-9.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Elevated systolic blood pressure and risk of cardiovascular and renal disease: overview of evidence from observational epidemiologic studies and randomized controlled trials</article-title>
          <source>Am Heart J</source>
          <date>
            <year>1999</year>
          </date>
          <fpage>211</fpage>
          <lpage>9</lpage>
          <volume>138</volume>
          <person-group person-group-type="author">
            <name>
              <surname>He</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Whelton</surname>
              <given-names>PK</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B5">
        <mixed-citation>5. Hajjar I, Kotchen TA. Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988-2000. JAMA. 2003; 290: 199-206.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988-2000</article-title>
          <source>JAMA</source>
          <date>
            <year>2003</year>
          </date>
          <fpage>199</fpage>
          <lpage>206</lpage>
          <volume>290</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Hajjar</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Kotchen</surname>
              <given-names>TA</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B6">
        <mixed-citation>6. Gus I, Harzheim E, Zaslavsky C, Medina C, Gus M. Prevalence, awareness, and control of systemic arterial hypertension in the state of Rio Grande do Sul. Arq Bras Cardiol. 2004; 83: 429-33.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Prevalence, awareness, and control of systemic arterial hypertension in the state of Rio Grande do Sul</article-title>
          <source>Arq Bras Cardiol</source>
          <date>
            <year>2004</year>
          </date>
          <fpage>429</fpage>
          <lpage>33</lpage>
          <volume>83</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Gus</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Harzheim</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Zaslavsky</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Medina</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Gus</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B7">
        <mixed-citation>7. Souza ARA, Costa A, Nakamura D, Mocheti LN, Filho PRS, Ovando LA. A study on systemic arterial hypertension in Campo Grande, MS, Brazil. Arq Bras Cardiol. 2007; 88: 441-6.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>A study on systemic arterial hypertension in Campo Grande, MS, Brazil</article-title>
          <source>Arq Bras Cardiol</source>
          <date>
            <year>2007</year>
          </date>
          <fpage>441</fpage>
          <lpage>6</lpage>
          <volume>88</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Souza</surname>
              <given-names>ARA</given-names>
            </name>
            <name>
              <surname>Costa</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Nakamura</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Mocheti</surname>
              <given-names>LN</given-names>
            </name>
            <name>
              <surname>Filho</surname>
              <given-names>PRS</given-names>
            </name>
            <name>
              <surname>Ovando</surname>
              <given-names>LA</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B8">
        <mixed-citation>8. Castro RAA, Moncau JEC, Marcopito LF. Hypertension prevalence in the city of Formiga, MG (Brazil). Arq Bras Cardiol. 2007; 88: 301-6.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Hypertension prevalence in the city of Formiga, MG (Brazil)</article-title>
          <source>Arq Bras Cardiol</source>
          <date>
            <year>2007</year>
          </date>
          <fpage>301</fpage>
          <lpage>6</lpage>
          <volume>88</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Castro</surname>
              <given-names>RAA</given-names>
            </name>
            <name>
              <surname>Moncau</surname>
              <given-names>JEC</given-names>
            </name>
            <name>
              <surname>Marcopito</surname>
              <given-names>LF</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B9">
        <mixed-citation>9. Freitas OC, Carvalho FR, Neves JM, Veludo PK, Parreira RS, Gon&#231;alves RM, et al. Prevalence of hypertension in the urban population of Catanduva, in the state of S&#227;o Paulo, Brazil. Arq Bras Cardiol. 2001; 77: 16-21.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Prevalence of hypertension in the urban population of Catanduva, in the state of S&#227;o Paulo, Brazil</article-title>
          <source>Arq Bras Cardiol</source>
          <date>
            <year>2001</year>
          </date>
          <fpage>16</fpage>
          <lpage>21</lpage>
          <volume>77</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Freitas</surname>
              <given-names>OC</given-names>
            </name>
            <name>
              <surname>Carvalho</surname>
              <given-names>FR</given-names>
            </name>
            <name>
              <surname>Neves</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>Veludo</surname>
              <given-names>PK</given-names>
            </name>
            <name>
              <surname>Parreira</surname>
              <given-names>RS</given-names>
            </name>
            <name>
              <surname>Gon&#231;alves</surname>
              <given-names>RM</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B10">
        <mixed-citation>10. Brazilian Institute for Geography and Statistics (IBGE). Information about population census. [Accessed 2004 July 02]. Available at: <ext-link ext-link-type="uri" xlink:href="http://www.ibge.gov.br/censo">http://www.ibge.gov.br/censo</ext-link></mixed-citation>
        <element-citation publication-type="book">
          <source>Information about population census</source>
        </element-citation>
      </ref>
      <ref id="B11">
        <mixed-citation>11. Kish L. Survey sampling. New York: John Wiley &amp; Sons; 1995.</mixed-citation>
        <element-citation publication-type="book">
          <source>Survey sampling</source>
          <date>
            <year>1995</year>
          </date>
          <person-group person-group-type="author">
            <name>
              <surname>Kish</surname>
              <given-names>L</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B12">
        <mixed-citation>12. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, et al. National High Blood Pressure Education Program Coordinating Committee. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension. 2003; 42: 1206-52.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>National High Blood Pressure Education Program Coordinating Committee. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure</article-title>
          <source>Hypertension</source>
          <date>
            <year>2003</year>
          </date>
          <fpage>1206</fpage>
          <lpage>52</lpage>
          <volume>42</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Chobanian</surname>
              <given-names>AV</given-names>
            </name>
            <name>
              <surname>Bakris</surname>
              <given-names>GL</given-names>
            </name>
            <name>
              <surname>Black</surname>
              <given-names>HR</given-names>
            </name>
            <name>
              <surname>Cushman</surname>
              <given-names>WC</given-names>
            </name>
            <name>
              <surname>Green</surname>
              <given-names>LA</given-names>
            </name>
            <name>
              <surname>Izzo Jr</surname>
              <given-names>JL</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B13">
        <mixed-citation>13. Krieger N, Williams DR, Moss NE. Measuring social class in U.S. public health research: concepts, methodologies, and guidelines. Annu Rev Publ Health. 1997; 18: 341-78.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Measuring social class in U.S. public health research: concepts, methodologies, and guidelines</article-title>
          <source>Annu Rev Publ Health</source>
          <date>
            <year>1997</year>
          </date>
          <fpage>341</fpage>
          <lpage>78</lpage>
          <volume>18</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Krieger</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Williams</surname>
              <given-names>DR</given-names>
            </name>
            <name>
              <surname>Moss</surname>
              <given-names>NE</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B14">
        <mixed-citation>14. Zhu S, Wang Z, Heshka S, Heo M, Faith MS, Heymsfield SB. Waist circumference and obesity-associated risk factors among whites in the third National Health  and Nutrition Examination Survey: clinical action thresholds. Am J Clin Nutr. 2002; 76: 743-9.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Waist circumference and obesity-associated risk factors among whites in the third National Health and Nutrition Examination Survey: clinical action thresholds</article-title>
          <source>Am J Clin Nutr</source>
          <date>
            <year>2002</year>
          </date>
          <fpage>743</fpage>
          <lpage>9</lpage>
          <volume>76</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Zhu</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>Z</given-names>
            </name>
            <name>
              <surname>Heshka</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Heo</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Faith</surname>
              <given-names>MS</given-names>
            </name>
            <name>
              <surname>Heymsfield</surname>
              <given-names>SB</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B15">
        <mixed-citation>15. Bray GA, Gray DS. Treatment of obesity: an overview. Diabetes Metab Rev. 1988; 4: 653-79.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Treatment of obesity: an overview</article-title>
          <source>Diabetes Metab Rev</source>
          <date>
            <year>1988</year>
          </date>
          <fpage>653</fpage>
          <lpage>79</lpage>
          <volume>4</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Bray</surname>
              <given-names>GA</given-names>
            </name>
            <name>
              <surname>Gray</surname>
              <given-names>DS</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B16">
        <mixed-citation>16. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, et al. American Heart Association, National Heart, Lung, and Blood Institute. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation. 2005; 112: 2735-52.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>American Heart Association, National Heart, Lung, and Blood Institute. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement</article-title>
          <source>Circulation</source>
          <date>
            <year>2005</year>
          </date>
          <fpage>2735</fpage>
          <lpage>52</lpage>
          <volume>112</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Grundy</surname>
              <given-names>SM</given-names>
            </name>
            <name>
              <surname>Cleeman</surname>
              <given-names>JI</given-names>
            </name>
            <name>
              <surname>Daniels</surname>
              <given-names>SR</given-names>
            </name>
            <name>
              <surname>Donato</surname>
              <given-names>KA</given-names>
            </name>
            <name>
              <surname>Eckel</surname>
              <given-names>RH</given-names>
            </name>
            <name>
              <surname>Franklin</surname>
              <given-names>BA</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B17">
        <mixed-citation>17. Bisi Molina MC, Cunha RS, Herkenhoff LF, Mill JG. Hypertension and salt intake in an urban population. Rev Sa&#250;de P&#250;blica. 2003; 37: 743-50.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Hypertension and salt intake in an urban population</article-title>
          <source>Rev Sa&#250;de P&#250;blica</source>
          <date>
            <year>2003</year>
          </date>
          <fpage>743</fpage>
          <lpage>50</lpage>
          <volume>37</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Bisi Molina</surname>
              <given-names>MC</given-names>
            </name>
            <name>
              <surname>Cunha</surname>
              <given-names>RS</given-names>
            </name>
            <name>
              <surname>Herkenhoff</surname>
              <given-names>LF</given-names>
            </name>
            <name>
              <surname>Mill</surname>
              <given-names>JG</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B18">
        <mixed-citation>18. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2007; 30 (Suppl 1): S42-S47.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Diagnosis and classification of diabetes mellitus</article-title>
          <source>Diabetes Care</source>
          <date>
            <year>2007</year>
          </date>
          <fpage>S42</fpage>
          <lpage>S47</lpage>
          <volume>30</volume>
        </element-citation>
      </ref>
      <ref id="B19">
        <label>19</label>
        <mixed-citation>19. Minitab Statistical Software, Minitab Inc. [Accessed 2006 Oct 01]. Available at: <ext-link ext-link-type="uri" xlink:href="http://www.minitab.com">http://www.minitab.com</ext-link></mixed-citation>
        <element-citation publication-type="webpage">
          <comment>Available at:<ext-link ext-link-type="uri" xlink:href="http://http://www.minitab.com">link</ext-link></comment>
        </element-citation>
      </ref>
      <ref id="B20">
        <mixed-citation>20. R 2.4.1 - A Language and Environment: the R Development Core Team. [Accessed 2006 Nov 10]. Available at: <ext-link ext-link-type="uri" xlink:href="http://www.r-project.org">http://www.r-project.org</ext-link></mixed-citation>
        <element-citation publication-type="book">
          <source>A Language and Environment: the R Development Core Team</source>
          <date>
            <day>10</day>
            <month>11</month>
            <year>2006</year>
          </date>
        </element-citation>
      </ref>
      <ref id="B21">
        <mixed-citation>21. Bishop YMM, Fienberg SE, Holland PW. Discrete multivariate analysis: theory and practice. Cambridge: the MIT Press; 1975. p. 492-500.</mixed-citation>
        <element-citation publication-type="book">
          <source>Discrete multivariate analysis: theory and practice</source>
          <date>
            <year>1975</year>
          </date>
          <person-group person-group-type="author">
            <name>
              <surname>Bishop</surname>
              <given-names>YMM</given-names>
            </name>
            <name>
              <surname>Fienberg</surname>
              <given-names>SE</given-names>
            </name>
            <name>
              <surname>Holland</surname>
              <given-names>PW</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B22">
        <mixed-citation>22. Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J. Global burden of hypertension: analysis of worldwide data. Lancet. 2005; 365: 217-23.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Global burden of hypertension: analysis of worldwide data</article-title>
          <source>Lancet</source>
          <date>
            <year>2005</year>
          </date>
          <fpage>217</fpage>
          <lpage>23</lpage>
          <volume>365</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Kearney</surname>
              <given-names>PM</given-names>
            </name>
            <name>
              <surname>Whelton</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Reynolds</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Muntner</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Whelton</surname>
              <given-names>PK</given-names>
            </name>
            <name>
              <surname>He</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B23">
        <mixed-citation>23. Joffres MR, Hamet P, MacLean DR, L'italien GJ, Fodor G. Distribution of blood pressure and hypertension in Canada and the United States. Am J Hypertens. 2001; 14: 1099-105.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Distribution of blood pressure and hypertension in Canada and the United States</article-title>
          <source>Am J Hypertens</source>
          <date>
            <year>2001</year>
          </date>
          <fpage>1099</fpage>
          <lpage>105</lpage>
          <volume>14</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Joffres</surname>
              <given-names>MR</given-names>
            </name>
            <name>
              <surname>Hamet</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>MacLean</surname>
              <given-names>DR</given-names>
            </name>
            <name>
              <surname>L'italien GJ</surname>
            </name>
            <name>
              <surname>Fodor</surname>
              <given-names>G</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B24">
        <mixed-citation>24. Ord&#250;&#241;ez P, Silva LC, Rodriguez MP, Robles S. Prevalence estimates for hypertension in Latin America and Caribbean: are they useful for surveillance? Pan Am J Public Health. 2001; 10: 226-31.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Prevalence estimates for hypertension in Latin America and Caribbean: are they useful for surveillance?</article-title>
          <source>Pan Am J Public Health</source>
          <date>
            <year>2001</year>
          </date>
          <fpage>226</fpage>
          <lpage>31</lpage>
          <volume>10</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Ord&#250;&#241;ez</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Silva</surname>
              <given-names>LC</given-names>
            </name>
            <name>
              <surname>Rodriguez</surname>
              <given-names>MP</given-names>
            </name>
            <name>
              <surname>Robles</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B25">
        <mixed-citation>25. Ong KL, Cheung BMY, Man YB, Lau CP, Lam KSL. Prevalence, awareness, treatment, and control of hypertension among United States adults 1999-2004. Hypertension. 2007; 49: 69-75.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Prevalence, awareness, treatment, and control of hypertension among United States adults 1999-2004</article-title>
          <source>Hypertension</source>
          <date>
            <year>2007</year>
          </date>
          <fpage>69</fpage>
          <lpage>75</lpage>
          <volume>49</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Ong</surname>
              <given-names>KL</given-names>
            </name>
            <name>
              <surname>Cheung</surname>
              <given-names>BMY</given-names>
            </name>
            <name>
              <surname>Man</surname>
              <given-names>YB</given-names>
            </name>
            <name>
              <surname>Lau</surname>
              <given-names>CP</given-names>
            </name>
            <name>
              <surname>Lam</surname>
              <given-names>KSL</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B26">
        <mixed-citation>26. Hajjar I, Kotchen JM, Kotchen TA. Hypertension: trends in prevalence, incidence, and control. Annu Rev Public Health. 2006; 27: 465-90.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Hypertension: trends in prevalence, incidence, and control</article-title>
          <source>Annu Rev Public Health</source>
          <date>
            <year>2006</year>
          </date>
          <fpage>465</fpage>
          <lpage>90</lpage>
          <volume>27</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Hajjar</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Kotchen</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>Kotchen</surname>
              <given-names>TA</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B27">
        <mixed-citation>27. Centers for Disease Control and Prevention (CDC). Racial/ethnic disparities in prevalence, treatment, and control of hypertension - United States, 1999-2002. MMWR Morb Mort Wkly Rep. 2005; 54: 7-9.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Racial/ethnic disparities in prevalence, treatment, and control of hypertension - United States, 1999-2002</article-title>
          <source>MMWR Morb Mort Wkly Rep</source>
          <date>
            <year>2005</year>
          </date>
          <fpage>7</fpage>
          <lpage>9</lpage>
          <volume>54</volume>
        </element-citation>
      </ref>
      <ref id="B28">
        <mixed-citation>28. Kanjilal S, Gregg EW, Cheng Y, Zhang P, Nelson DE, Mensah G, et al. Socioeconomic status and trends in disparities in 4 major risk factors for cardiovascular disease among US Adults, 1971-2002. Arch Intern Med. 2006; 166: 2348-55.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Socioeconomic status and trends in disparities in 4 major risk factors for cardiovascular disease among US Adults, 1971-2002</article-title>
          <source>Arch Intern Med</source>
          <date>
            <year>2006</year>
          </date>
          <fpage>2348</fpage>
          <lpage>55</lpage>
          <volume>166</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Kanjilal</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Gregg</surname>
              <given-names>EW</given-names>
            </name>
            <name>
              <surname>Cheng</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Nelson</surname>
              <given-names>DE</given-names>
            </name>
            <name>
              <surname>Mensah</surname>
              <given-names>G</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B29">
        <mixed-citation>29. Winkleby MA, Jatulis DE, Frank E, Fortmann SP. Socioeconomic status and health: how education, income, and occupation contribute to risk factors for cardiovascular disease. Am J Public Health. 1992; 82: 816-20.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Socioeconomic status and health: how education, income, and occupation contribute to risk factors for cardiovascular disease</article-title>
          <source>Am J Public Health</source>
          <date>
            <year>1992</year>
          </date>
          <fpage>816</fpage>
          <lpage>20</lpage>
          <volume>82</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Winkleby</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>Jatulis</surname>
              <given-names>DE</given-names>
            </name>
            <name>
              <surname>Frank</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Fortmann</surname>
              <given-names>SP</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B30">
        <mixed-citation>30. Hunt SC, Williams RR, Barlow GK. A comparison of positive family history definitions for defining risk of future disease. J Chronic Dis. 1986; 39: 809-21.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>A comparison of positive family history definitions for defining risk of future disease</article-title>
          <source>J Chronic Dis</source>
          <date>
            <year>1986</year>
          </date>
          <fpage>809</fpage>
          <lpage>21</lpage>
          <volume>39</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Hunt</surname>
              <given-names>SC</given-names>
            </name>
            <name>
              <surname>Williams</surname>
              <given-names>RR</given-names>
            </name>
            <name>
              <surname>Barlow</surname>
              <given-names>GK</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B31">
        <mixed-citation>31. Muldoon MF, Terrell DF, Bunker CH, Manuck SB. Family history studies in hypertension research: review of the literature. Am J Hypertens. 1993; 6: 76-88.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Family history studies in hypertension research: review of the literature</article-title>
          <source>Am J Hypertens</source>
          <date>
            <year>1993</year>
          </date>
          <fpage>76</fpage>
          <lpage>88</lpage>
          <volume>6</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Muldoon</surname>
              <given-names>MF</given-names>
            </name>
            <name>
              <surname>Terrell</surname>
              <given-names>DF</given-names>
            </name>
            <name>
              <surname>Bunker</surname>
              <given-names>CH</given-names>
            </name>
            <name>
              <surname>Manuck</surname>
              <given-names>SB</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B32">
        <mixed-citation>32. Kaufman JS, Asuzu MC, Mufunda J, Forrester T, Wilks R, Luke A, et al. Relationship between blood pressure and body mass index in lean populations. Hypertension. 1997; 30: 1511-6.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Relationship between blood pressure and body mass index in lean populations</article-title>
          <source>Hypertension</source>
          <date>
            <year>1997</year>
          </date>
          <fpage>1511</fpage>
          <lpage>6</lpage>
          <volume>30</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Kaufman</surname>
              <given-names>JS</given-names>
            </name>
            <name>
              <surname>Asuzu</surname>
              <given-names>MC</given-names>
            </name>
            <name>
              <surname>Mufunda</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Forrester</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Wilks</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Luke</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B33">
        <mixed-citation>33. Gallagher D, Visser M, Sepulveda D, Pierson RN, Harris T, Heymsfield SB. How useful is body mass index for comparison of body fatness across age, sex and ethnic groups. Am J Epidemiol. 1996; 143: 228-39.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>How useful is body mass index for comparison of body fatness across age, sex and ethnic groups</article-title>
          <source>Am J Epidemiol</source>
          <date>
            <year>1996</year>
          </date>
          <fpage>228</fpage>
          <lpage>39</lpage>
          <volume>143</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Gallagher</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Visser</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Sepulveda</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Pierson</surname>
              <given-names>RN</given-names>
            </name>
            <name>
              <surname>Harris</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Heymsfield</surname>
              <given-names>SB</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B34">
        <mixed-citation>34. Gus M, Fuchs SC, Moreira LB, Moraes RS, Wiehe M, Silva AF, et al. Association between different measurements of obesity and the incidence of hypertension. Am J Hypertens. 2004; 17: 50-3.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Association between different measurements of obesity and the incidence of hypertension</article-title>
          <source>Am J Hypertens</source>
          <date>
            <year>2004</year>
          </date>
          <fpage>50</fpage>
          <lpage>3</lpage>
          <volume>17</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Gus</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Fuchs</surname>
              <given-names>SC</given-names>
            </name>
            <name>
              <surname>Moreira</surname>
              <given-names>LB</given-names>
            </name>
            <name>
              <surname>Moraes</surname>
              <given-names>RS</given-names>
            </name>
            <name>
              <surname>Wiehe</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Silva</surname>
              <given-names>AF</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B35">
        <mixed-citation>35. National Diabetes Statistics. Total prevalence of diabetes in the United States, all ages, 2005. [Acessed 2007 July 10]. Available at <ext-link ext-link-type="uri" xlink:href="http://diabetes.niddk.nih.gov/dm/pubs/statistics/index.htm#7">http://diabetes.niddk.nih.gov/dm/pubs/statistics/index.htm#7</ext-link>;</mixed-citation>
        <element-citation publication-type="book">
          <source>Total prevalence of diabetes in the United States, all ages, 2005</source>
        </element-citation>
      </ref>
      <ref id="B36">
        <mixed-citation>36. Intersalt: an international study of electrolyte excretion and blood pressure: results for 24-hour urinary sodium and potassium excretion. Intersalt Cooperative Research Group. BMJ. 1988; 297: 319-28.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Intersalt: an international study of electrolyte excretion and blood pressure</article-title>
          <source>BMJ</source>
          <date>
            <year>1988</year>
          </date>
          <fpage>319</fpage>
          <lpage>28</lpage>
          <volume>297</volume>
        </element-citation>
      </ref>
      <ref id="B37">
        <mixed-citation>37. Law MR. Epidemiologic evidence on salt and blood pressure. Am J Hypertens. 1997; 10 (Suppl 1): S42-S45.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Epidemiologic evidence on salt and blood pressure</article-title>
          <source>Am J Hypertens</source>
          <date>
            <year>1997</year>
          </date>
          <fpage>S42</fpage>
          <lpage>S45</lpage>
          <volume>10</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Law</surname>
              <given-names>MR</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B38">
        <mixed-citation>38. Ordunez-Garcia P, Munoz JL, Pedraza D, Espinosa-Brito A, Silva LC, Cooper RS. Success in control of hypertension in a low-resource setting: the Cuban experience. J Hypertens. 2006; 24: 845-9.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Success in control of hypertension in a low-resource setting: the Cuban experience</article-title>
          <source>J Hypertens</source>
          <date>
            <year>2006</year>
          </date>
          <fpage>845</fpage>
          <lpage>9</lpage>
          <volume>24</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Ordunez-Garcia</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Munoz</surname>
              <given-names>JL</given-names>
            </name>
            <name>
              <surname>Pedraza</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Espinosa-Brito</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Silva</surname>
              <given-names>LC</given-names>
            </name>
            <name>
              <surname>Cooper</surname>
              <given-names>RS</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
    </ref-list>
  </back>
  <sub-article article-type="translation" id="TRes" xml:lang="es">
    <front-stub>
      <article-categories/>
      <title-group>
        <article-title xml:lang="es">Prevalencia y factores de riesgo para hipertensi&#243;n en una poblaci&#243;n urbana brasilera</article-title>
      </title-group>
      <abstract xml:lang="es">
        <p>FUNDAMENTO: Los estudios existentes no han analizado de modo amplio los varios factores comprendidos en la g&#233;nesis de la hipertensi&#243;n (HT), especialmente la asociaci&#243;n entre presi&#243;n arterial, excreci&#243;n urinaria de sodio y disfunci&#243;n renal. OBJETIVO: Evaluar la prevalencia de los factores de riesgo para HT en diferentes grupos etarios, en una muestra representativa de una poblaci&#243;n urbana brasilera. M&#201;TODOS: La poblaci&#243;n estudiada (1.717 individuos adultos) fue evaluada por grupos etarios: 18 a 39 a&#241;os; 40 a 49; 50 a 59; 60 a 69 y &gt; 70 a&#241;os. Se compararon los promedios de las variables cuantitativas y las variables categ&#243;ricas de los grupos normotenso e hipertenso. RESULTADOS: La prevalencia general ajustada para HT fue del 25,23%. La prevalencia aument&#243; con la edad y era m&#225;s alta en individuos con bajo nivel educacional. El &#237;ndice de masa corporal y la circunferencia abdominal aumentados se asociaron positivamente con una mayor prevalencia de HT. Hab&#237;a una asociaci&#243;n positiva significante entre HT y excreci&#243;n urinaria de sodio. Los individuos hipertensos presentaban mayor frecuencia de disfunci&#243;n renal, definida como clearance de creatinina &lt; 60 ml/min/m&#178;. La prevalencia de diabetes mellitus en la poblaci&#243;n general era del 5,6% y 14,5% en los individuos hipertensos. La hipertensi&#243;n era una condici&#243;n conocida por el 74,4% de los individuos hipertensos. Entre los individuos hipertensos tratados, el 52,4% ten&#237;an una hipertensi&#243;n controlada y s&#243;lo el 34,3% de los pacientes hipertensos en general (tratados o no) ten&#237;an la presi&#243;n arterial controlada. CONCLUSI&#211;N: Este estudio de base poblacional es especial, debido al hecho de agregar diferentes factores demogr&#225;ficos, epidemiol&#243;gicos y de riesgo comprendidos en la g&#233;nesis de la hipertensi&#243;n en la evaluaci&#243;n de una &#250;nica muestra con un c&#225;lculo poblacional que puede ser extrapolado a otras poblaciones hipertensas.</p>
      </abstract>
      <kwd-group xml:lang="es">
        <kwd>Hipertensi&#243;n</kwd>
        <kwd>epidemiolog&#237;a y bioestad&#237;stica</kwd>
        <kwd>tasa de filtrado glomerular</kwd>
        <kwd>factores de riesgo</kwd>
        <kwd>edad</kwd>
      </kwd-group>
    </front-stub>
    <body>
      <p>
        <bold>ART&#205;CULO ORIGINAL</bold>
      </p>
      <p>
        <fn id="top-body2">
          <label>
            <bold>Prevalencia y factores de riesgo para hipertensi&#243;n en una poblaci&#243;n urbana brasilera</bold>
          </label>
          <p>
            <bold>Jos&#233; Paulo Cipullo; Jos&#233; Fernando Vilela Martin; Luiz Alberto de Souza Ciorlia; Maria Regina Pereira de Godoy; Jo&#227;o Castilho Ca&#231;&#227;o; Afonso Augusto Carvalho Loureiro; Cl&#225;udia Bernardi Cesarino; Ant&#244;nio C Carvalho; Jos&#233; Ant&#244;nio Cordeiro; Emmanuel de Almeida Burdmann</bold>
          </p>
        </fn>
      </p>
      <p>Faculdade de Medicina de S&#227;o Jos&#233; do Rio Preto/SP (FAMERP), S&#227;o Paulo, SP - Brasil</p>
      <p>Correspondencia</p>
      <p>
        <bold>RESUMEN</bold>
      </p>
      <p><bold>FUNDAMENTO: </bold> Los estudios existentes no han analizado de modo amplio los varios factores comprendidos en la g&#233;nesis de la hipertensi&#243;n (HT), especialmente la asociaci&#243;n entre presi&#243;n arterial, excreci&#243;n urinaria de sodio y disfunci&#243;n renal.</p>
      <p><bold>OBJETIVO:</bold> Evaluar la prevalencia de los factores de riesgo para HT en diferentes grupos etarios, en una muestra representativa de una poblaci&#243;n urbana brasilera.</p>
      <p><bold>M&#201;TODOS:</bold> La poblaci&#243;n estudiada (1.717 individuos adultos) fue evaluada por grupos etarios: 18 a 39 a&#241;os; 40 a 49; 50 a 59; 60 a 69 y &gt; 70 a&#241;os. Se compararon los promedios de las variables cuantitativas y las variables categ&#243;ricas de los grupos normotenso e hipertenso.</p>
      <p><bold>RESULTADOS:</bold> La prevalencia general ajustada para HT fue del 25,23%. La prevalencia aument&#243; con la edad y era m&#225;s alta en individuos con bajo nivel educacional. El &#237;ndice de masa corporal y la circunferencia abdominal aumentados se asociaron positivamente con una mayor prevalencia de HT. Hab&#237;a una asociaci&#243;n positiva significante entre HT y excreci&#243;n urinaria de sodio. Los individuos hipertensos presentaban mayor frecuencia de disfunci&#243;n renal, definida como clearance de creatinina &lt; 60 ml/min/m<sup>2</sup>. La prevalencia de diabetes mellitus en la poblaci&#243;n general era del 5,6% y 14,5% en los individuos hipertensos. La hipertensi&#243;n era una condici&#243;n conocida por el 74,4% de los individuos hipertensos. Entre los individuos hipertensos tratados, el 52,4% ten&#237;an una hipertensi&#243;n controlada y s&#243;lo el 34,3% de los pacientes hipertensos en general (tratados o no) ten&#237;an la presi&#243;n arterial controlada.</p>
      <p><bold>CONCLUSI&#211;N:</bold> Este estudio de base poblacional es especial, debido al hecho de agregar diferentes factores demogr&#225;ficos, epidemiol&#243;gicos y de riesgo comprendidos en la g&#233;nesis de la hipertensi&#243;n en la evaluaci&#243;n de una &#250;nica muestra con un c&#225;lculo poblacional que puede ser extrapolado a otras poblaciones hipertensas.</p>
      <p><bold>Palabras clave: </bold> Hipertensi&#243;n, epidemiolog&#237;a y bioestad&#237;stica, tasa de filtrado glomerular, factores de riesgo, edad.</p>
      <p>
        <bold>Introducci&#243;n</bold>
      </p>
      <p>La enfermedad cardiovascular (ECV) es la mayor causa de mortalidad en pa&#237;ses desarrollados. En Brasil, la ECV es responsable por cerca del 30% de la mortalidad general y por 1,2 millones de hospitalizaciones, con un costo aproximado de 650 millones de d&#243;lares/a&#241;o<sup>1,2</sup>.</p>
      <p>La hipertensi&#243;n (HT) es la m&#225;s prevalente de todas las ECV, y afecta a m&#225;s de 36 millones de brasile&#241;os adultos. Est&#225; considerada el mayor factor de riesgo para lesiones card&#237;acas y cerebrovasculares y la tercera causa de invalidez<sup>1,2</sup>. La HT est&#225; probablemente implicada en el 50% de las muertes causadas por ECV<sup>3,4</sup>. El control de la presi&#243;n arterial es cr&#237;tico para la prevenci&#243;n de lesiones org&#225;nicas inducidas por la hipertensi&#243;n, pero la naturaleza asintom&#225;tica de esta patolog&#237;a hace que sea sub-diagnosticada y por consiguiente sub-tratada, a pesar de su alta prevalencia.</p>
      <p>De hecho, el <italic>National Health and Nutrition Examination Survey</italic> (NHANES) observ&#243; que el 28,7% de los individuos evaluados eran hipertensos, el 68,9% sab&#237;a de su condici&#243;n, el 58,4% era tratado y s&#243;lo el 31% hab&#237;a logrado un control efectivo de la presi&#243;n arterial<sup>5</sup>.</p>
      <p>En Brasil, la prevalencia de hipertensi&#243;n y los factores de riesgo asociados han sido evaluados desde finales de la d&#233;cada del 70, con una amplia variaci&#243;n entre los diferentes estudios. Esta disparidad probablemente resulta de la falta de estandarizaci&#243;n de la metodolog&#237;a y criterios de selecci&#243;n de los individuos analizados<sup>6-9</sup>. Otro posible factor es la gran heterogeneidad entre diferentes regiones del pa&#237;s, donde coexisten &#225;reas desarrolladas y en desarrollo. Adem&#225;s, los estudios disponibles no analizaron completamente los varios factores involucrados en la g&#233;nesis de la hipertensi&#243;n, especialmente la asociaci&#243;n entre la presi&#243;n arterial, excreci&#243;n urinaria de sodio y disfunci&#243;n renal.</p>
      <p>El objetivo de este estudio fue evaluar la prevalencia de los factores de riesgo para hipertensi&#243;n en diferentes grupos etarios en una muestra representativa de una poblaci&#243;n urbana brasilera.</p>
      <p>
        <bold>M&#233;todos</bold>
      </p>
      <p>Este proyecto fue aprobado por el Comit&#233; de &#201;tica en Investigaciones de la Escuela de Medicina de S&#227;o Jos&#233; do Rio Preto. Todos los participantes fueron informados e instruidos sobre los resultados del test y firmaron el consentimiento informado antes de su inclusi&#243;n en el estudio.</p>
      <p>En 2004 y 2005 se llev&#243; a cabo un estudio transversal en una muestra representativa de la poblaci&#243;n urbana adulta (<underline>&gt;</underline> 18 a&#241;os) en S&#227;o Jos&#233; do Rio Preto, estado de S&#227;o Paulo, Brasil. La muestra fue estratificada por edad de acuerdo con los datos del Instituto Brasile&#241;o de Geograf&#237;a y Estad&#237;stica (IBGE). En el momento de la investigaci&#243;n, S&#227;o Jos&#233; do Rio Preto ten&#237;a una poblaci&#243;n de cerca de 370.000 habitantes, con un predominio de individuos de raza blanca (82,8%) y una distribuci&#243;n equilibrada entre hombres (48,4%) y mujeres (51,6%)<sup>10</sup>. Los grupos etarios evaluados fueron: 18 a 39 a&#241;os; 40 a 49; 50 a 59; 60 a 69 y <underline>&gt;</underline> 70 a&#241;os. Los par&#225;metros usados para calcular los tama&#241;os de muestra de las franjas etarias fueron el n&#250;mero de habitantes, la prevalencia esperada de hipertensi&#243;n para cada grupo etario, m&#225;ximo permitido intervalo de confianza de 95%, semi-amplitud de 3%<sup>11</sup>.</p>
      <p>La ciudad fue dividida en los sectores censatarios utilizados por el IBGE. En cada sector, el n&#250;mero de individuos fue estudiado de acuerdo con la proporcionalidad de la poblaci&#243;n. Para cada regi&#243;n, fueron escogidos al azar calles, residencias y un adulto que viv&#237;a desde hac&#237;a m&#225;s de seis meses en la residencia y que completaba los criterios de inclusi&#243;n. Luego de haber sido escogida la primera residencia de la calle, los entrevistadores atravesaban la calle y "salteaban" dos casas. Cuando el individuo escogido no acordaba en participar, un vecino en la casa de al lado era escogido de la misma forma. Los criterios de exclusi&#243;n inclu&#237;an gravidez, enfermedades psiqui&#225;tricas graves o incapacidad mental e individuos postrados.</p>
      <p>Los entrevistadores fueron previamente entrenados y monitoreados por un coordinador de campo. Los participantes respondieron un cuestionario que inclu&#237;a datos personales, renta y propiedades para evaluar el nivel socioecon&#243;mico, nivel de escolaridad, hist&#243;rico m&#233;dico personal y familiar, conocimiento de la hipertensi&#243;n y medicamentos que utilizaba.</p>
      <p>Despu&#233;s de esto, los m&#233;dicos verificaron las entrevistas y midieron la presi&#243;n arterial (PA), frecuencia cardiaca (FC) y datos antropom&#233;tricos. Los participantes fueron instruidos para hacer ayuno durante la noche y recolectar la orina de 12 horas para los test bioqu&#237;micos. Al d&#237;a siguiente a la primera visita, la orina recolectada fue recogida y se tom&#243; una muestra de sangre en ayunas.</p>
      <p>La t&#233;cnica de medici&#243;n de la PA fue aquella estandarizada por el <italic>VII Joint National Committee</italic><sup>12</sup>: 1) las mediciones fueron realizadas con un esfigmoman&#243;metro aneroide recientemente calibrado, cuya precisi&#243;n era conocida; 2) el manguito se coloc&#243; de forma que el borde inferior quedase 3 cm por encima del pliegue del codo y la abrazadera fue colocada centralmente sobre la arteria braquial; 3) se utiliz&#243; una abrazadera est&#225;ndar (12-13 cm de largo y 35 cm de ancho), y se dispon&#237;a de abrazaderas mayores y menores, para brazos m&#225;s gruesos o m&#225;s finos, respectivamente; 4) el brazo estaba desnudo y apoyado con el manguito de presi&#243;n arterial a nivel del coraz&#243;n; 5) se utiliz&#243; el promedio de tres mediciones de PA en la posici&#243;n sentada tras 5 a 10 minutos de descanso; 6) para identificar la PA sist&#243;lica e diast&#243;lica, fueron registradas las fases I y V (desaparici&#243;n) de los sonidos de Korotkoff, respectivamente; 7) la presi&#243;n se aument&#243; r&#225;pidamente a 30 mmHg por encima del nivel en el que se extingu&#237;a el pulso radial; 8) se utiliz&#243; una taza de deflaci&#243;n del manguito de 2 mmHg por latido; 9) se recomend&#243; un intervalo de por lo menos 1 minuto entre las lecturas, a fin de evitar congesti&#243;n venosa; 10) la PA fue medida en ambos brazos para detectar posibles diferencias debido a patolog&#237;a vascular perif&#233;rica; en ese caso, se tom&#243; el mayor valor como referencia. La hipertensi&#243;n se defini&#243; como PA sist&#243;lica <underline>&gt;</underline> 140 mmHg y/o PA diast&#243;lica <underline>&gt;</underline> 90 mmHg, o uso corriente de medicamentos antihipertensivos. Los individuos fueron clasificados como pacientes normotensos (N), pacientes con hipertensi&#243;n desconocida, con hipertensi&#243;n tratada y controlada y con hipertensi&#243;n tratada y no-controlada. Para los individuos con valores lim&#237;trofes de PA, se obtuvo una nueva medici&#243;n en un d&#237;a diferente en el mismo horario de la &#250;ltima medici&#243;n.</p>
      <p>El nivel socioecon&#243;mico fue clasificado en A, B, C, D o E (basado en la renta familiar y propiedades, siendo A y B los niveles m&#225;s altos). Los niveles A y B fueron considerados con una renta familiar por encima de 10 salarios m&#237;nimos, el nivel C, entre 3 y 5 salarios m&#237;nimos y los niveles D/E, por debajo de 3 salarios m&#237;nimos. El nivel de escolaridad fue definido por el n&#250;mero de a&#241;os de estudio y la muestra fue dividida en 3 grupos: E<sub>1</sub> hasta 7 a&#241;os de escolaridad, E<sub>2</sub> 8 a 10 a&#241;os de escolaridad y E<sub>3</sub><underline>&gt;</underline> 11 a&#241;os de escolaridad, incluyendo la educaci&#243;n universitaria<sup>13</sup>.</p>
      <p>El &#237;ndice de masa corporal (IMC) se obtuvo mediante la relaci&#243;n peso/altura<sup>2</sup> (kg/m<sup>2</sup>). El examen fue realizado con los individuos con los pies descalzos, vistiendo ropas leves. Para la medici&#243;n del peso se utiliz&#243; una balanza port&#225;til calibrada. La altura y la circunferencia abdominal (CA) fueron medidas en cent&#237;metros usando una cinta m&#233;trica. La medida de la CA fue realizada utilizando la mitad de la distancia entre la cresta il&#237;aca superior anterior y la &#250;ltima costilla, al final de la expiraci&#243;n. El IMC clasific&#243; a los individuos como normal (&lt; 25), sobrepeso (25 a 29,9) u obeso (<underline>&gt;</underline> 30 kg/m<sup>2</sup>) (<xref ref-type="table" rid="t1-body2">Tabla 1</xref>)<sup>14,15</sup>. La variaci&#243;n normal de la CA fue la utilizada por el <italic>National Cholesterol Education Program</italic> - ATPIII<sup>16</sup> y los individuos fueron divididos en 3 grupos (<xref ref-type="table" rid="t1-body2">Tabla 1</xref>).</p>
      <table-wrap id="t1-body2">
        <graphic xlink:href="1678-4170-abc-94-04-0519-00014-gt01-es.jpg"/></table-wrap>
      <p>El sodio urinario (mEq/l) fue evaluado mediante fotometr&#237;a de llama. La excreci&#243;n del sodio urinario fue calculada multiplicando la concentraci&#243;n del sodio urinario en mEq/l por el volumen urinario de 12 horas<sup>17</sup> y los participantes fueron divididos en: grupo Na<sup>+</sup> I con sodio urinario &lt; 100mEq/12h, grupo Na<sup>+</sup> II con sodio urinario &gt; 100 y &lt; 150 mEq/12h y grupo Na<sup>+</sup> III con sodio urinario <underline>&gt;</underline> 150 mEq/12h. Fueron evaluados el volumen urinario de 12 horas y las concentraciones de creatinina urinaria y en plasma, para calcular el clearance de creatinina ajustado a la superficie corporal.</p>
      <p>El diagn&#243;stico de diabetes mellitus (DM) se estableci&#243; por los antecedentes, el uso de medicamentos hipoglucemiantes y la medici&#243;n de la glucosa s&#233;rica<sup>18</sup>. Para las mediciones de glucemia y creatinina se utilizaron el m&#233;todo colorim&#233;trico, el dispositivo Dimension RXL y el reactivo Dade Behring. La <xref ref-type="table" rid="t1-body2">Tabla 1</xref> muestra la variaci&#243;n categ&#243;rica para los test bioqu&#237;micos.</p>
      <p>
        <bold>An&#225;lisis estad&#237;stico</bold>
      </p>
      <p>El an&#225;lisis estad&#237;stico se realiz&#243; utilizando el programa Minitab versi&#243;n 12.22 y R 2.4.1<sup>19,20</sup>. Se calcularon los promedios de las variables cuantitativas para cada grupo etario, y los grupos normotenso e hipertenso fueron comparados mediante el Test t de Student. Las variables categ&#243;ricas (obesidad, sexo, escolaridad, etc.) y el control de la PA fueron estimadas mediante el test de chi-cuadrado de Pearson o test exacto de Fisher. Las asociaciones de la hipertensi&#243;n y PA normal con las mismas variables categ&#243;ricas, seg&#250;n el grupo etario, fueron evaluadas mediante el test de la raz&#243;n de verosimilitud para muestras independientes. Como las muestras fueron estratificadas de acuerdo con el grupo etario, debido al an&#225;lisis, la poblaci&#243;n total debe ser considerada como una mezcla de sub-poblaciones, los grupos etarios: 18 a 39 a&#241;os, 40 a 49, 50 a 59, 60 a 69, &#179; 70 a&#241;os, respectivamente ponderados por 0,5533; 0,1855; 0,1229; 0,0820 y 0,0573. As&#237;, cualquier proporci&#243;n a ser evaluada en la poblaci&#243;n es una combinaci&#243;n convexa de la proporci&#243;n de las franjas, cuyos estimadores son independientes unos de otros.</p>
      <p>La evaluaci&#243;n de las estructuras de asociaci&#243;n de la PA con cualquier otra variable de la poblaci&#243;n fue realizada mediante aproximaci&#243;n multinormal con la combinaci&#243;n convexa, ponderada con pesos encima, de distribuciones multinormales para las frecuencias de las muestras en los estratos. La prevalencia y <italic>odds ratios (OR)</italic> fueron analizados a trav&#233;s de transformaciones lineares del logaritmo natural de las frecuencias relativas combinadas<sup>21</sup>.</p>
      <p>
        <bold>Resultados</bold>
      </p>
      <p>Cinco por ciento de los individuos sorteados no acept&#243; participar en el estudio y fue estudiado un grupo de 1.717 adultos, con edades entre 18 y 93 a&#241;os (55,0 &#177; 14,7 a&#241;os); 838 hombres (48,8%, 55,1 &#177; 14,9 a&#241;os) y 879 mujeres (51,2%, 55,0 &#177; 14,4 a&#241;os).</p>
      <p>De la muestra total, 762 individuos eran hipertensos. La prevalencia estimada y ajustada de la hipertensi&#243;n para esa poblaci&#243;n fue del 25,23% (IC95% [21,4, 30,0]. La edad del grupo hipertenso ajustada para la poblaci&#243;n de la ciudad fue 44,9 a&#241;os (IC95% [43,9, 45,6]) para mujeres y 42,4 (IC95% [40,8, 43,9]) para hombres. La edad del grupo normotenso ajustada para la poblaci&#243;n fue de 43,7 a&#241;os (IC95% [43,2, 44,4]) para mujeres y 50,0 (IC95% [49,4, 50,8]) para hombres.</p>
      <p>La prevalencia de la hipertensi&#243;n aument&#243; progresiva y significativamente con la edad hasta los 69 a&#241;os (p&lt;0,001). No se observ&#243; ninguna diferencia entre los grupos de 60 a 69 a&#241;os y <underline>&gt;</underline> 70 a&#241;os de edad (ver <xref ref-type="table" rid="es_14t02-body2">Tabla 2</xref>).</p>
      <p content-type="asset">
        <table-wrap id="es_14t02-body2">
          <graphic xlink:href="1678-4170-abc-94-04-0519-00014-gt02-es.jpg"/></table-wrap>
      </p>
      <p>La prevalencia de la hipertensi&#243;n fue similar en mujeres (26,8%) y hombres (23,8%), excepto en el grupo etario <underline>&gt;</underline> 70 a&#241;os, con una mayor prevalencia entre mujeres (82,4%), comparadas a los hombres (57,1%, p &lt; 0,05).</p>
      <p>La poblaci&#243;n estudiada inclu&#237;a un 79,6% de individuos blancos y un 20,4% de individuos no blancos, con una prevalencia de hipertensi&#243;n del 25,0% y 26,9%, respectivamente (<xref ref-type="table" rid="es_14t03-body2">Tabla 3</xref>).</p>
      <p content-type="asset">
        <table-wrap id="es_14t03-body2">
          <graphic xlink:href="1678-4170-abc-94-04-0519-00014-gt03-es.jpg"/></table-wrap>
      </p>
      <p>Con relaci&#243;n al nivel de escolaridad, se observ&#243; la siguiente distribuci&#243;n poblacional: E<sub>1</sub> un 44,6% (IC95%, 41,0-48,2); E<sub>2</sub> un 16,1% (IC95%, 13,1-19,2) y E<sub>3</sub> un 39,3% (IC95%, 35,5-43,1). La prevalencia de hipertensi&#243;n fue mayor en el grupo E<sub>1,</sub> comparado con los otros dos grupos (p &lt; 0,005), y no se observ&#243; ninguna diferencia entre los grupos E<sub>2</sub> e E<sub>3</sub> (<xref ref-type="table" rid="es_14t03-body2">Tabla 3</xref>).</p>
      <p>Los niveles socioecon&#243;micos fueron agrupados en AB, C y DE. Las estimativas de nivel socioecon&#243;mico para la poblaci&#243;n adulta fueron: AB un 19,8% (IC95%, 17,0-22,7); C un 43,2% (IC95%, 39,4-47,0) y DE un 37% (IC95%, 33,2-40,7). La prevalencia estimada de la hipertensi&#243;n fue similar en todos los niveles sociales, excepto el nivel DE comparado al C (<xref ref-type="table" rid="es_14t03-body2">Tabla 3</xref>).</p>
      <p>En el grupo hipertenso se observaron antecedentes familiares positivos para hipertensi&#243;n, comparado al grupo normotenso, en individuos con edad <underline>&gt;</underline> 50 a&#241;os (p &lt; 0,05). En el grupo etario de 60 a 69 a&#241;os los antecedentes familiares positivos para hipertensi&#243;n alcanzaron una prevalencia del 75,1% (p = 0,001), comparado al 23,9% en los individuos normotensos).</p>
      <p>El IMC era normal en el 44,6% de la poblaci&#243;n estudiada; el 33,2% ten&#237;a sobrepeso y el 22,2% obesidad, vale decir, el 55,4% ten&#237;a un IMC por encima del normal. En todos los grupos etarios se observ&#243; una mayor prevalencia de hipertensi&#243;n en individuos con sobrepeso y obesos, comparados a aquellos con IMC normal (p &lt; 0,001) (<xref ref-type="table" rid="es_14t03-body2">Tabla 3</xref>). La prevalencia de hipertensi&#243;n aument&#243; progresivamente de acuerdo con el aumento de la CA en todos los grupos etarios (p &lt; 0,0005).</p>
      <p>La prevalencia estimada de diabetes fue del 5,6% (IC95%, 4,5-6,7) en la poblaci&#243;n en general, del 14,5% (IC95%, 12,7-17,4) en individuos hipertensos y del 2,5% (IC95%, 2,1-3,0) en individuos normotensos (p &lt; 0,0005). Existi&#243; una clara asociaci&#243;n entre diabetes e hipertensi&#243;n (p &lt; 0,05) en todos los grupos etarios &gt; 50 a&#241;os. Cuando los grupos hipertenso y normotenso fueron comparados con relaci&#243;n a la presencia de diabetes mellitus, se observ&#243; un OR de 6,54 (IC95%, 3,73-11,42; p &lt; 0,0005).</p>
      <p>La prevalencia estimada de hipertensi&#243;n fue del 21,6% para el grupo Na<sup>+</sup> I (IC95%, 17,9-26,1), del 28,8% para el grupo Na<sup>+</sup> II (IC95%, 22,8-36,3) y del 32,8% para el grupo Na<sup>+</sup> III (IC95%, 25,5-42,2), con una mayor prevalencia de hipertensi&#243;n en el grupo Na<sup>+</sup> II, comparado al grupo Na<sup>+</sup> I (p = 0,03) y en el grupo Na<sup>+</sup> III comparado al grupo Na<sup>+</sup> I (p = 0,006). No hubo diferencias en la prevalencia de hipertensi&#243;n entre los grupos Na<sup>+</sup> II y Na<sup>+</sup> III. La presencia de sodio urinario <underline>&gt;</underline> 150 mEq/l fue m&#225;s frecuente en los individuos hipertensos que en los individuos normotensos, con riesgo de hipertensi&#243;n un 76% mayor con ese nivel de excreci&#243;n de sodio (<xref ref-type="table" rid="t4-body2">Tabla 4</xref>).</p>
      <table-wrap id="t4-body2">
        <graphic xlink:href="1678-4170-abc-94-04-0519-00014-gt04-es.jpg"/></table-wrap>
      <p>El clearance de creatinina (ClCr) fue analizado en 1.306 individuos. Valores &lt; 60 ml/min/m<sup>2</sup> fueron observados en el 5,4% de los individuos normotensos y en el 20,8% de los individuos hipertensos (<xref ref-type="table" rid="t4-body2">Tabla 4</xref>). Cuando se compar&#243; a los individuos hipertensos con los normotensos, se observ&#243; que 295 (96,4%) de aquellos con ClCr &lt; 60 ml/min/m<sup>2</sup> ten&#237;an <underline>&gt;</underline> 50 a&#241;os de edad.</p>
      <p>La hipertensi&#243;n era una condici&#243;n conocida por el 74,4% (IC95%, 71,3-77,5) de los individuos hipertensos y era desconocida por el 25,6% (IC95%, 22,5-28,7). Entre los individuos hipertensos tratados, el 52,4% (IC95%, 48,2-56,6) ten&#237;a la PA controlada. Entre todos los individuos hipertensos (tratados o no) s&#243;lo un 34,3% ten&#237;a la PA controlada.</p>
      <p>
        <bold>Discusi&#243;n</bold>
      </p>
      <p>La prevalencia de la hipertensi&#243;n es mayor en pa&#237;ses desarrollados que en pa&#237;ses en desarrollo, pero la gran masa poblacional en pa&#237;ses en desarrollo ha contribuido de forma significante al n&#250;mero total de individuos hipertensos en todo el mundo. Se estima que alrededor del 2025, 1,5 billones de personas ser&#225;n hipertensos<sup>22</sup>. Actualmente, la prevalencia promedio mundial estimada de la hipertensi&#243;n es del 26,4%, con una amplia variaci&#243;n que depende de la poblaci&#243;n estudiada, alcanzando un 21,0% en los EUA y Canad&#225;, un 33,5 a 39,7% en los pa&#237;ses europeos, un 15 a 21,7% en los pa&#237;ses africanos y asi&#225;ticos y cerca del 40% en Am&#233;rica Latina<sup>22-24</sup>.</p>
      <p>La prevalencia de la hipertensi&#243;n en Brasil var&#237;a del 24,8 al 44,4%<sup>6-9</sup>. En el presente estudio, la prevalencia de hipertensi&#243;n fue evaluada de acuerdo a los grupos etarios, determinando un n&#250;mero de individuos proporcional al n&#250;mero de habitantes para cada grupo etario y ajust&#225;ndolos a la poblaci&#243;n adulta. Esta caracter&#237;stica del presente estudio es distinta de la mayor&#237;a de los estudios anteriores, los que incluyeron un n&#250;mero representativo de mujeres y ancianos. Adem&#225;s, pocos estudios anteriores evaluaron simult&#225;neamente los factores de riesgo m&#225;s importantes para hipertensi&#243;n en la misma poblaci&#243;n. La prevalencia estimada de hipertensi&#243;n en la poblaci&#243;n estudiada fue del 25,3% y se observ&#243; un aumento progresivo con la edad, llegando al 70% entre los individuos mayores de 70 a&#241;os. Con el prop&#243;sito de comparaci&#243;n, los grupos etarios fueron reagrupados utilizando criterios similares a aquellos adoptados por el estudio NHANES 2003-2004<sup>25</sup> y se aplic&#243; el test c<sup>2</sup>, obteni&#233;ndose resultados similares (<xref ref-type="table" rid="t5-body2">Tabla 5</xref>). El evidente aumento en la prevalencia de la hipertensi&#243;n despu&#233;s de los 40 a&#241;os de edad y el potencial manejo de los factores de riesgo modificables para hipertensi&#243;n apoyan la adopci&#243;n inmediata de medidas preventivas y educacionales, que representan una importante inversi&#243;n en salud p&#250;blica.</p>
      <table-wrap id="t5-body2">
        <graphic xlink:href="1678-4170-abc-94-04-0519-00014-gt05-es.jpg"/></table-wrap>
      <p>La prevalencia de hipertensi&#243;n no fue diferente entre los sexos, a&#250;n cuando la poblaci&#243;n fue estratificada en diferentes grupos etarios, excepto en mujeres con edad <underline>&gt;</underline> 70 a&#241;os, lo que tambi&#233;n fue demostrado por otros autores<sup>26</sup>.</p>
      <p>No existieron diferencias significativas en la prevalencia de hipertensi&#243;n entre los diversos grupos &#233;tnicos en la poblaci&#243;n estudiada, a&#250;n cuando estudios norteamericanos hayan relatado una mayor prevalencia y gravedad de la hipertensi&#243;n en individuos negros. Es posible que el mayor n&#250;mero de individuos blancos en la poblaci&#243;n actual o el mayor grado de mestizaje en Brasil hayan influido sobre los resultados obtenidos<sup>27</sup>.</p>
      <p>Las diferencias socioecon&#243;micas juegan un papel importante en las condiciones de salud que sufren la influencia de diferentes factores, tales como el acceso al sistema de salud, el grado de informaci&#243;n, la comprensi&#243;n de la condici&#243;n m&#233;dica y la adherencia al tratamiento<sup>28</sup>. Diferentes estudios mostraron &#237;ndices m&#225;s altos de ECV en grupos con nivel socioecon&#243;mico m&#225;s bajo<sup>29</sup>. No obstante, no hubo diferencia significativa en la prevalencia de la hipertensi&#243;n con relaci&#243;n al nivel socioecon&#243;mico en el presente estudio, a pesar de una tendencia a la mayor prevalencia en las clases C y D/E. Es posible que &#233;sta sea una caracter&#237;stica distinta de pa&#237;ses en desarrollo. Individuos con nivel de escolaridad m&#225;s bajo presentaron una mayor prevalencia de hipertensi&#243;n en todos los grupos etarios. Cuando se compar&#243; el OR, utilizando el nivel de escolaridad m&#225;s alto como referencia, el riesgo de hipertensi&#243;n fue 2,8 veces mayor para aquellos con nivel de escolaridad m&#225;s bajo, lo que tambi&#233;n se observ&#243; en el NHANES, que mostr&#243; un OR de 1,14 (IC95%, 1,01 a 1,97) para prevalencia de hipertensi&#243;n en el grupo con nivel de escolaridad m&#225;s bajo<sup>25</sup>.</p>
      <p>No existieron diferencias significativas entre individuos normotensos e hipertensos, con relaci&#243;n a los antecedentes familiares, para los grupos etarios hasta 49 a&#241;os. Sin embargo, despu&#233;s de los 50 a&#241;os de edad, hubo una mayor prevalencia de antecedentes familiares positivos en individuos hipertensos, lo que puede explicar las diferencias observadas<sup>30,31</sup>.</p>
      <p>Se observ&#243; una relaci&#243;n linear en todos los grupos etarios entre el IMC y la PA, as&#237; como con la CA. Sobrepeso y obesidad son factores de riesgo reales para hipertensi&#243;n, pues individuos en esos grupos etarios presentaban un aumento de 2 y 3,6 veces el riesgo de tener hipertensi&#243;n, respectivamente. Tambi&#233;n hab&#237;a una relaci&#243;n proporcional entre la prevalencia de la hipertensi&#243;n y el aumento de la CA. De hecho, la CA y el IMC son considerados buenos predictores de riesgo de desarrollar hipertensi&#243;n<sup>32-34</sup>. En el presente estudio, el riesgo de hipertensi&#243;n estaba m&#225;s relacionado a la obesidad definida por la mayor CA, que al IMC mayor, como observaron otros autores<sup>34</sup>.</p>
      <p>La prevalencia de la DM fue mayor en individuos hipertensos, con un OR de 6,54, lo que arrastra una carga adicional para enfermedad cardiovascular. Es posible que el da&#241;o endotelial promovido por la DM haya contribuido al desarrollo de la hipertensi&#243;n en esa poblaci&#243;n. La prevalencia de diabetes en la poblaci&#243;n norteamericana es de aproximadamente el 7% y un 30% de ellos desconocen su condici&#243;n. La prevalencia de DM aumenta con la edad, llegando al 20% en individuos con edad <underline>&gt;</underline> 60 a&#241;os<sup>35</sup>, lo que fue similar al &#237;ndice del 22% observado en este grupo etario del presente estudio (datos no informados).</p>
      <p>La excreci&#243;n urinaria de sodio present&#243; una correlaci&#243;n positiva y significativa con los niveles de PA en todos los grupos etarios. Estos resultados, raramente descritos en estudios de prevalencia de hipertensi&#243;n, indican una asociaci&#243;n positiva entre el consumo de sal, excreci&#243;n de sodio urinario y prevalencia de hipertensi&#243;n<sup>36,37</sup>.</p>
      <p>La disfunci&#243;n renal, evaluada a trav&#233;s del clearance de creatinina &lt; 60/ml/min, fue m&#225;s prevalente entre individuos hipertensos. De hecho, individuos hipertensos presentaron un riesgo 4,5 veces mayor de disfunci&#243;n renal, especialmente luego de los 50 a&#241;os de edad. Este resultado sugiere una posible asociaci&#243;n entre hipertensi&#243;n y disfunci&#243;n renal, independiente de la edad.</p>
      <p>Estudios poblacionales han mostrado diversos grados de conocimiento de la hipertensi&#243;n por individuos hipertensos. En los pa&#237;ses europeos, estos niveles var&#237;an de un 52,7% en Alemania a un 70% en Suecia. En Am&#233;rica del Norte, la tasa de conocimiento es del 82,1% en los EUA. La tasa de control de la PA en la poblaci&#243;n hipertensa en general tambi&#233;n var&#237;a. En Europa las tasas var&#237;an del 22,9% en Espa&#241;a al 37,7% en Inglaterra. En el presente estudio el grado de conocimiento de la hipertensi&#243;n era alto y similar a aquellos encontrados por el estudio NHANES. En el presente estudio, entre los individuos hipertensos tratados, cerca del 50% ten&#237;an la PA controlada y cerca del 30% de los pacientes hipertensos en general, ten&#237;an la PA controlada. Estos datos tambi&#233;n son similares a los del estudio NHANES 2003-2004, que mostr&#243; que la tasa de control ajustada por la edad era del 63,9% para individuos hipertensos tratados y del 33,1% para los pacientes hipertensos en general<sup>25</sup>. Estos resultados favorables se deben probablemente a las informaciones adecuadas dadas al p&#250;blico sobre la enfermedad, inversi&#243;n en el entrenamiento de profesionales de la salud, participaci&#243;n de equipos multidisciplinarios en el sistema de salud local, disponibilidad de medicamentos antihipertensivos proporcionados por el gobierno sin costo y una pol&#237;tica m&#225;s agresiva a nivel de cuidados primarios, como se observa en otros pa&#237;ses en desarrollo<sup>38</sup>.</p>
      <p>Algunas limitaciones del presente estudio deben ser mencionadas. Primero, las directrices de la <italic>American Diabetes Association</italic> recomiendan la confirmaci&#243;n de la hiperglucemia en una segunda medici&#243;n, lo que no fue hecho en este estudio. Por otro lado, los estudios epidemiol&#243;gicos, entre ellos el NHANES, utilizan casi exclusivamente una &#250;nica medici&#243;n de glucosa en sangre para el diagn&#243;stico de DM. Segundo, el consumo de sal se bas&#243; en una &#250;nica medici&#243;n de la excreci&#243;n de sodio, lo que tambi&#233;n vale para la evaluaci&#243;n del filtrado glomerular a trav&#233;s de una &#250;nica medida de clearance de creatinina. En el presente estudio, tampoco estudiamos el perfil lip&#237;dico, un hecho que no nos permite evaluar la dimensi&#243;n de las alteraciones metab&#243;licas asociadas con la hipertensi&#243;n.</p>
      <p>Por otro lado, este estudio de base poblacional, con un grupo control normotenso, es especial porque agrega diferentes factores demogr&#225;ficos, epidemiol&#243;gicos y de riesgo involucrados en la g&#233;nesis de la hipertensi&#243;n y de las ECV en la evaluaci&#243;n de una &#250;nica muestra, con un c&#225;lculo poblacional que puede ser extrapolado para otras poblaciones hipertensas.</p>
      <p>
        <bold>Agradecimientos</bold>
      </p>
      <p>Agradecemos a Livia C. Burdmann por la cuidadosa revisi&#243;n gramatical del manuscrito. Tambi&#233;n gustar&#237;amos de agradecer a Carla G. R. Carvalho, Lina Galli y Rosemara S. Machado por su ayuda con las entrevistas. Finalmente, queremos agradecer la ayuda de Elisabeth R. R. Zago y Fernanda R. Campos. El Dr. Emmanuel A. Burdmann tiene apoyo financiero parcial del CNPq.</p>
      <p>
        <bold>Potencial Conflicto de Intereses</bold>
      </p>
      <p>Declaro no haber conflicto de intereses pertinentes.</p>
      <p>
        <bold>Fuentes de Financiaci&#243;n</bold>
      </p>
      <p>El presente estudio no tuvo fuentes de financiamiento externas.</p>
      <p>
        <bold>Vinculaci&#243;n Acad&#233;mica</bold>
      </p>
      <p>No hay vinculaci&#243;n de este estudio a programas de postgrado.</p>
      <p>
        <bold>Referencias</bold>
      </p>
    </body>
  </sub-article>
  <sub-article article-type="translation" id="TRen" xml:lang="en">
    <front-stub>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Original Articles</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title xml:lang="en">Hypertension prevalence and risk factors in a Brazilian urban population</article-title>
      </title-group>
      <abstract xml:lang="en">
        <p>BACKGROUND: The available studies have not fully analyzed the several factors involved in the genesis of hypertension (HT), especially the association among blood pressure, urinary sodium excretion and renal dysfunction. OBJECTIVE: To assess the HT prevalence and risk factors in different age groups in a representative sample of an urban Brazilian population. METHODS: The studied population (1717 adult individuals) was evaluated by age groups: 18 to 39 years; 40 to 49; 50 to 59; 60 to 69 and &gt; 70 years. Quantitative variable means and categorical variables of the hypertensive and normotensive groups were compared. RESULTS: The adjusted overall prevalence of HT was 25.23%. The prevalence increased with age and was higher in individuals with low educational level. Increased body mass index and abdominal waist were positively related to a higher prevalence of HT. There was a significant positive association between HT and urinary sodium excretion. Hypertensive individuals presented higher frequency of renal dysfunction, defined as measured creatinine clearance &lt;60 ml/min/m&#178;. The prevalence of diabetes mellitus was 5.6% in the overall population and 14.5% in hypertensive individuals. Hypertension was a known condition to 74.4% of the hypertensive individuals. Among treated hypertensive individuals, 52.4% achieved controlled blood pressure and only 34.3% of the overall hypertensive patients (treated or not) had blood pressure controlled. CONCLUSION: This population-based is unique by gathering different demographic, epidemiologic and risk factors involved in the genesis of hypertension in a single sample assessment with a population calculation, which might be extrapolated to other hypertensive populations.</p>
      </abstract>
      <kwd-group xml:lang="en">
        <kwd>Hypertension</kwd>
        <kwd>epidemiology and biostatistics</kwd>
        <kwd>glomerular filtration rate</kwd>
        <kwd>risk factors</kwd>
        <kwd>age</kwd>
      </kwd-group>
    </front-stub>
    <body>
      <p>
        <bold>ORIGINAL ARTICLE</bold>
      </p>
      <p><undefined id="linkinicio-body3"/>Hypertension prevalence and risk factors in a Brazilian urban population</p>
      <p>
        <bold>Jos&#233; Paulo Cipullo; Jos&#233; Fernando Vilela Martin; Luiz Alberto de Souza Ciorlia; Maria Regina Pereira de Godoy; Jo&#227;o Castilho Ca&#231;&#227;o; Afonso Augusto Carvalho Loureiro; Cl&#225;udia Bernardi Cesarino; Ant&#244;nio C Carvalho; Jos&#233; Ant&#244;nio Cordeiro; Emmanuel de Almeida Burdmann</bold>
      </p>
      <p>Faculdade de Medicina de S&#227;o Jos&#233; do Rio Preto/SP (FAMERP), S&#227;o Paulo, SP - Brazil</p>
      <p>Mailing address</p>
      <p>
        <bold>ABSTRACT</bold>
      </p>
      <p><bold>BACKGROUND:</bold> The available studies have not fully analyzed the several factors involved in the genesis of hypertension (HT), especially the association among blood pressure, urinary sodium excretion and renal dysfunction.</p>
      <p><bold>OBJECTIVE:</bold> To assess the HT prevalence and risk factors in different age groups in a representative sample of an urban Brazilian population.</p>
      <p><bold>METHODS:</bold> The studied population (1717 adult individuals) was evaluated by age groups: 18 to 39 years; 40 to 49; 50 to 59; 60 to 69 and &gt; 70 years. Quantitative variable means and categorical variables of the hypertensive and normotensive groups were compared.</p>
      <p><bold>RESULTS:</bold> The adjusted overall prevalence of HT was 25.23%. The prevalence increased with age and was higher in individuals with low educational level. Increased body mass index and abdominal waist were positively related to a higher prevalence of HT. There was a significant positive association between HT and urinary sodium excretion. Hypertensive individuals presented higher frequency of renal dysfunction, defined as measured creatinine clearance &lt;60 ml/min/m<sup>2</sup>. The prevalence of diabetes mellitus was 5.6% in the overall population and 14.5% in hypertensive individuals. Hypertension was a known condition to 74.4% of the hypertensive individuals. Among treated hypertensive individuals, 52.4% achieved controlled blood pressure and only 34.3% of the overall hypertensive patients (treated or not) had blood pressure controlled.</p>
      <p><bold>CONCLUSION:</bold> This population-based is unique by gathering different demographic, epidemiologic and risk factors involved in the genesis of hypertension in a single sample assessment with a population calculation, which might be extrapolated to other hypertensive populations. (Arq Bras Cardiol 2010; 94(4):488-494)</p>
      <p><bold>Key words:</bold> Hypertension; epidemiology and biostatistics; glomerular filtration rate; risk factors; age.</p>
      <p>
        <bold>Introduction</bold>
      </p>
      <p>Cardiovascular disease (CVD) is the major cause of mortality in developed countries. In Brazil, CVD accounts for about 30% of the overall mortality and is responsible for 1.2 million hospitalizations with an approximate cost of 650 million dollars/year<sup>1,2</sup>. Hypertension is the most prevalent of all CVDs, affecting over 36 million adult Brazilians, is the major risk factor for cardio and cerebrovascular injury and is the third cause of disability<sup>1,2</sup>. Hypertension is likely to be involved in 50% of the deaths due to CVDs<sup>3,4</sup>. Blood pressure control is critical for the prevention of hypertension induced-organ injury, but the asymptomatic nature of this disease renders it underdiagnosed and consequently undertreated, despite its very high prevalence. In fact, The National Health and Nutrition Examination Survey (NHANES)observed that 28.7% of the assessed individuals were hypertensive, 68.9% knew their condition, 58.4% were treated, and only 31% achieved an effective blood pressure control<sup>5</sup>.</p>
      <p>In Brazil, the prevalence of hypertension and associated risk factors has been evaluated since the late 70s, with a wide variation among the different studies. This disparity probably results from the lack of methodological standardization and selection criteria of the screened individuals<sup>6-9</sup>. Other possible factor is the great heterogeneity found in different parts of the country, with coexisting developed and developing areas. Moreover, the available studies did not fully analyze the several factors involved in the genesis of hypertension, especially the association among the blood pressure, urinary sodium excretion and renal dysfunction.</p>
      <p>The objective of this study was to assess the prevalence and risk factors for hypertension in different age groups in a representative sample of an urban Brazilian population.</p>
      <p>
        <bold>Methods</bold>
      </p>
      <p>This project was approved by the Research Ethics Committee, S&#227;o Jos&#233; do Rio Preto Medical School. All of the participants were informed and instructed about the test results and signed an informed consent before enrollment in the study.</p>
      <p>In 2004 and 2005 a transversal study was carried out in a representative sample of the adult (<underline>&gt;</underline> 18 years) urban population in S&#227;o Jos&#233; do Rio Preto, State of S&#227;o Paulo, Brazil. The sample was stratified by age according to Brazilian Institute for Geography and Statistics (IBGE) data. At the time of the survey, S&#227;o Jos&#233; do Rio Preto had a population of about 370,000 inhabitants, a predominance of white individuals (82.8%) and a balanced distribution between men (48.4%) and women (51.6%)<sup>10</sup>. The evaluated age groups were 18 to 39 years; 40 to 49; 50 to 59; 60 to 69 and <underline>&gt;</underline> 70 years. The parameters used to calculate the strata sample sizes were number of inhabitants, expected prevalence of hypertension for each age group, maximum allowed 95% confidence interval semi amplitude of 3%<sup>11</sup>.</p>
      <p>The city was divided into the census sectors used by IBGE. In each sector, the number of individuals was studied according to the proportionality of the population. For each region, streets, homes and one adult who had been living for over six months in the house that met the inclusion and exclusion criteria was randomly chosen. After the first house at the street was chosen, interviewers went across the street and skipped two houses. In cases when the selected individual did not agree to participate, a next-door neighbor was chosen in the same way. The exclusion criteria were pregnancy, severe psychiatric diseases or mental disability and bedridden individuals.</p>
      <p>The interviewers were previously trained and monitored by a field coordinator. The participants answered a questionnaire that included personal data, income and properties to assess the socioeconomic level, level of education, personal and family medical history, awareness of hypertension and medications being used. After that, the physicians checked the interviews and measured blood pressure (BP), heart rate (HR) and anthropometric data. The participants were instructed to fast and collect 12-hour urine for biochemical tests. On the day following the first visit the collected urine was picked up and a fasting blood sample was drawn.</p>
      <p>The BP measurement technique was that standardized by the VII Joint National Committee<sup>12</sup>: 1) measurements were taken with a recently calibrated aneroid sphygmomanometer known to be accurate; 2) the cuff was placed so that the lower edge was 3 cm above the elbow crease and the bladder was centered over the brachial artery; 3) a standard bladder was used (12-13 cm long and 35 cm wide), but a larger and a smaller bladder were available for thicker and thinner arms, respectively; 4) the arm was bare and supported with the blood pressure cuff positioned at heart level; 5) the mean of three BP measurements taken in the sitting position after 5 to 10 minutes of rest was used; 6) phase I and V (disappearance) Korotkoff sounds were used to identify systolic and diastolic BP, respectively; 7) the pressure was increased rapidly to 30 mmHg above the level at which the radial pulse was extinguished; 8) a cuff deflation rate of 2 mmHg per beat was used; 9) a minimum of 1-minute intervals were recommended between readings to avoid venous congestion; 10) BP was measured in both arms to detect possible differences due to peripheral vascular disease; in this case, the higher value was taken as the reference one. Hypertension was defined as systolic BP <underline>&gt;</underline> 140mmHg and/or diastolic BP <underline>&gt;</underline> 90mmHg or current use of anti-hypertensive drugs. Individuals were classified as normotensive (N), unknown hypertensive condition, treated and controlled hypertensive condition and treated and not controlled hypertensive patients. For the individuals with borderline BP values, a new measurement was carried out on a different day at the same hour of the last day.</p>
      <p>The socioeconomic level was classified into A, B, C, D or E (based on family income and assets, with A and B being the highest). The A and B levels were considered in accordance with family income above ten minimum wages, the C level between three and five and D/E levels below three minimum wages. Educational level was defined by the number of years of study, and the sample was divided into three groups: E<sub>1</sub> up to 7 years of instruction, E<sub>2</sub> 8 to 10 years of instruction and E<sub>3</sub><underline>&gt;</underline> 11 years of instruction, including university education<sup>13</sup>.</p>
      <p>The body mass index (BMI) was obtained by the weight/height ratio (kg/m<sup>2</sup>). The examination was carried out with the bare-footed individuals wearing light clothes. A portable calibrated scale was used for weight measurement. Height and waist circumference (WC) were determined in centimeters using a measuring tape. The measurement of the WC was carried using the half of the distance between the anterior superior iliac crest and the last rib, at the end of expiration. The BMI classified individuals as normal (&lt;25), overweight (25 to 29.9) and obese (<underline>&gt;</underline>30 kg/m<sup>2</sup>) (<xref ref-type="table" rid="tab01-body3">table 1</xref>)<sup>14,15</sup>. The WC normal range was that recommended by the National Cholesterol Education Program - ATPIII<sup>16</sup> and the individuals were divided into three groups (<xref ref-type="table" rid="tab01-body3">Table 1</xref>). </p>
      <table-wrap id="tab01-body3">
        <graphic xlink:href="1678-4170-abc-94-04-0519-00014-gt01-en.jpg"/></table-wrap>
      <p>Urinary sodium (mEq/l) was assessed by flame photometry. Sodium urinary excretion was calculated by multiplying sodium urinary concentrations in mEq/L by 12-hour urinary volume<sup>17</sup>, and participants were divided into Na<sup>+</sup> I group with urinary sodium &lt;100mEq/12h, Na<sup>+</sup> II group with urinary sodium &gt;100 and &lt;150mEq/12h and Na<sup>+</sup> III with urinary sodium <underline>&gt;</underline> 150mEq/12h. Twelve-hour urinary volume and plasma and urinary creatinine concentrations were assessed to calculate creatinine clearance adjusted for body surface.</p>
      <p>The diagnosis of diabetes mellitus (DM) was established by history, use of glucose-lowering drugs and serum glucose measurement<sup>18</sup>. The colorimetric method and the Dimension RXL device and Dade Behring reagent were used for glycemia and creatinine measurements. <xref ref-type="table" rid="tab01-body3">Table 1</xref> shows the categorical range for biochemistry tests.</p>
      <p>
        <bold>Statistical analysis</bold>
      </p>
      <p>Statistical analysis was carried out by Minitab programs version 12.22 and R 2.4.1<sup>19,20</sup>. For each age group, quantitative variable means were calculated and the hypertensive and normotensive groups were compared by Student's t test. Categorical variables (obesity, gender, education, etc) and blood pressure control were estimated by Pearson's chi-square test, or by Fisher's exact test. Hypertension and normal BP associations with the same categorical variables, according to age group, were assessed by the likelihood ratio test for independent samples. As the samples were stratified according to the age group for the sake of the analysis, the whole population must be considered as a mixture of subpopulations, the age groups: 18 to 39 years, 40 to 49, 50 to 59, 60 to 69, <underline>&gt;</underline> 70, were respectively weighted by 0.5533; 0.1855;0.1229;0.0820 and 0.0573. Thus any proportion to be evaluated in the population is a convex combination of the strata proportions, of which estimators are independent of each other. The assessment of association structures of BP with any other population variable was carried out by the multinormal approximation with the above weights convex combinations of multinomial distributions for the frequencies of samples on the strata. Prevalence and <italic>odds ratios (OR)</italic> were analyzed by linear transformations of the natural logarithm of the combined relative frequencies<sup>21</sup>.</p>
      <p>
        <bold>Results</bold>
      </p>
      <p>Five percent of the drafted individuals declined to participate in the study and a group of 1,717 adults aged 18 to 93 years (55.0 &#177; 14.7 years), with 838 males (48.8%, 55.1 &#177; 14.9 years) and 879 females (51.2%, 55.0 &#177; 14.4 years) were screened. </p>
      <p>Of the overall sample, 762 individuals were hypertensive. The estimated and adjusted prevalence of hypertension for this population was 25.23% (95%CI [21.4, 30.0]). The hypertensive group age adjusted for the city population was 44.9 years (95%CI [43.9, 45.6]) for women and 42.4 (95%CI [40.8, 43.9]) for men. The normotensive group age adjusted for the population was 43.7 years (95%CI [43.2, 44.4]) for women and 50.0 (95%CI [49.4, 50.8]) for men.</p>
      <p>The prevalence of hypertension increased progressively and significantly with age up to 69 yrs (p&lt;0.001). No difference was observed between the groups 60 to 69 years and <underline>&gt;</underline> 70 years of age (see <xref ref-type="table" rid="en_a14tab02-body3">Table 2</xref>).</p>
      <p content-type="asset">
        <table-wrap id="en_a14tab02-body3">
          <graphic xlink:href="1678-4170-abc-94-04-0519-00014-gt02-en.jpg"/></table-wrap>
      </p>
      <p>The prevalence of hypertension was similar in females (26.8%) and males (23.8%), except in the age group <underline>&gt;</underline> 70 years, with a higher prevalence among women (82.4%) as compared to men (57.1%, p&lt;0.05).</p>
      <p>The studied population included 79.6% of white and 20.4% of non-white individuals, with a prevalence of hypertension of 25.0% and 26.9%, respectively (<xref ref-type="table" rid="en_a14tab03-body3">Table 3</xref>). </p>
      <p content-type="asset">
        <table-wrap id="en_a14tab03-body3">
          <graphic xlink:href="1678-4170-abc-94-04-0519-00014-gt03-en.jpg"/></table-wrap>
      </p>
      <p>As for the educational level, the following population distribution was observed: E<sub>1</sub> 44.6% (95% CI, 41.0-48.2); E<sub>2</sub> 16.1% (95% CI, 13.1-19.2) and E<sub>3</sub> 39.3% (95% CI, 35.5-43.1). The prevalence of hypertension was higher in group E<sub>1</sub> when compared to the other two groups (p&lt;0.005), and no difference was observed between groups E<sub>2</sub> and E<sub>3</sub> (<xref ref-type="table" rid="en_a14tab03-body3">table 3</xref>).</p>
      <p>Socioeconomic levels were grouped into AB, C and DE. Social level estimates for the adult population were AB 19.8% (95% CI, 17.0-22.7); C 43.2% (95% CI, 39.4-47.0) and DE 37% (95% CI, 33.2-40.7). The estimated prevalence of hypertension was similar in all social levels, except for the DE level when compared to C (<xref ref-type="table" rid="en_a14tab03-body3">Table 3</xref>).</p>
      <p>A positive family history for hypertension was observed in the hypertensive group when compared to the normotensive group for individuals <underline>&gt;</underline> 50 years (p&lt;0.05), with positive familial history for hypertension in the age group from 60 to 69 years reaching a prevalence of 75.1% (p=0.001 compared to 23.9% in normotensive individuals). </p>
      <p>The BMI was normal in 44.6% of the study population, 33.2% were overweight and 22.2% were obese, i.e., 55.4% had BMI above normal. A greater prevalence of hypertension was observed in all age groups for overweight and obese individuals when compared to those with a normal BMI (p&lt;0.001) (<xref ref-type="table" rid="en_a14tab03-body3">table 3</xref>). The prevalence of hypertension increased progressively according to waist circumference increases in all age groups (p&lt;0.0005). </p>
      <p>The estimated prevalence of diabetes was 5.6% (95%CI, 4.5-6.7) in the overall population, 14.5% (95% CI, 12.7-17.4) in hypertensive and 2.5% (95% CI, 2.1-3.0) in normotensive individuals (p&lt;0.0005). There was a clear association between diabetes and hypertension (p&lt;0.05) in all age groups greater than 50 years. When the hypertensive and normotensive groups were compared for the presence of diabetes mellitus, an OR of 6.54 (95% CI, 3.73-11.42; p&lt;0.0005) was observed.</p>
      <p>The estimated prevalence of hypertension was 21.6% for the Na<sup>+</sup> I group (95% CI, 17.9-26.1), 28.8% for the Na<sup>+</sup> II group (95% CI, 22.8-36.3) and 32.8% for the Na<sup>+</sup> III group (95% CI, 25.5-42.2), with a greater prevalence of hypertension in the Na<sup>+</sup> II group when compared to the Na<sup>+ </sup>I group (p = 0.03) and the Na<sup>+ </sup>III group compared to the Na<sup>+ </sup>I group (p = 0.006). There were no differences in hypertension prevalence between the Na<sup>+</sup> II and Na<sup>+</sup> III groups. The presence of the urinary sodium <underline>&gt;</underline> 150 mEq/l was more frequent in hypertensive than in normotensive individuals with a 76% greater risk of hypertension with this level of sodium excretion (<xref ref-type="table" rid="en_a14tab04-body3">Table 4</xref>).</p>
      <p content-type="asset">
        <table-wrap id="en_a14tab04-body3">
          <graphic xlink:href="1678-4170-abc-94-04-0519-00014-gt04-en.jpg"/></table-wrap>
      </p>
      <p>Creatinine clearance (CrCl) was performed in 1,306 individuals. Values lower than 60 ml/min/m<sup>2</sup> were observed in 5.4% of the normotensive individuals and 20.8% of the hypertensive individuals (<xref ref-type="table" rid="en_a14tab04-body3">Table 4</xref>). When hypertensive and normotensive individuals were compared, it was observed that 295 (96.4%) of those with CrCl &lt;60 ml/min/m<sup>2</sup> were <underline>&gt;</underline> 50 years of age.</p>
      <p>Hypertension was a known condition to 74.4% (95% CI, 71.3-77.5) of the hypertensive individuals, and it was unknown to 25.6% (95% CI, 22.5-28.7). Among treated hypertensive individuals, 52.4% (95% CI, 48.2-56.6) had controlled blood pressure. Among all hypertensive individuals (treated or not), only 34.3% had controlled blood pressure.</p>
      <p>
        <bold>Discussion</bold>
      </p>
      <p>The prevalence of hypertension is higher in developed than in developing countries, but the large population mass in developing countries has significantly contributed to the overall number of hypertensive individuals worldwide. It is estimated that by 2025, 1.5 billion people will be hypertensive<sup>22</sup>. Currently, the estimated mean worldwide prevalence of hypertension is 26.4%, with a broad variation depending on the study population, reaching 21.0% in the USA and Canada, 33.5 to 39.7% in European countries, 15 to 21.7% in African and Asian countries and about 40% in Latin America<sup>22-24</sup>.</p>
      <p>The prevalence of hypertension in Brazil ranges from 24.8 to 44.4%<sup>6-9</sup>. In the present study, the prevalence of hypertension was evaluated according to age groups, determining a number of individuals proportional to the number of inhabitants for each age group and adjusting them for the adult population. This feature of the present study is distinct from most of the previous reports, which included an expressive number of women and elderly individuals. Moreover, few previous studies assessed simultaneously the most important risk factors for hypertension in the same population. The estimated prevalence of hypertension in the studied population was 25.3%, and a progressive increase was observed with age, reaching 70% in those older than 70 years. For comparison purposes, age groups were re-grouped using similar criteria to those adopted by NHANES 2003-2004<sup>25 </sup>and &#967;<sup>2</sup> test was applied and similar results were obtained (<xref ref-type="table" rid="tab05-body3">Table 5</xref>). The clear increase in the prevalence of hypertension after 40 years of age and the potential for management of modifiable risk factors for hypertension urges the immediate adoption of preventive and educational measures, representing an important investment in public health. </p>
      <table-wrap id="tab05-body3">
        <graphic xlink:href="1678-4170-abc-94-04-0519-00014-gt05-en.jpg"/></table-wrap>
      <p>The prevalence of hypertension was not different between genders, even when the population was stratified by the different age groups, except for women <underline>&gt;</underline> 70 years, which was also demonstrated by other authors<sup>26</sup>.</p>
      <p>There were no significant differences in the prevalence of hypertension among diverse ethnic groups in the studied population, although North-American studies reported a greater prevalence and severity of hypertension in blacks. It is possible that the large number of white individuals in the current population and the high level of ethnic miscegenation in Brazil might have influenced the obtained results<sup>27</sup>.</p>
      <p>Socioeconomic differences play an important role in health conditions influencing different factors such as access to the health system, degree of information, understanding of medical conditions and compliance to therapy<sup>28</sup>. Different studies showed higher CVD rates among lower socioeconomic level groups<sup>29</sup>. However, there was no significant difference in the prevalence of hypertension related to social levels in the present study, despite a tendency to higher prevalence in classes C and D/E. It is possible that this is a distinctive characteristic of developing countries.</p>
      <p>Individuals with lower educational levels showed a higher prevalence of hypertension in all age groups. When the OR was compared, using the higher educational level as a reference, the risk for hypertension was 2.8-times higher for those with lower schooling, which was also observed by the NHANES, which has shown an OR of 1.14 (95% CI, 1.01 to 1.97) for hypertension prevalence in the group with a lower degree of schooling<sup>25</sup>.</p>
      <p>There was no significant difference between normotensive and hypertensive individuals regarding family history for age groups up to 49 years. However, after 50 years of age, there was a greater prevalence of positive family history in hypertensive individuals which might explain the differences observed<sup>30, 31</sup>.</p>
      <p>A linear association was found in all age groups between BMI and BP, as well as WC. Overweight and obesity are actual risk factors for hypertension, as individuals in these age groups had a 2-fold and 3.6-fold higher risk of having hypertension, respectively. There is also a proportional association between the prevalence of hypertension and the increase in waist circumference. In fact, waist circumference and BMI are considered good predictors of the risk of developing hypertension<sup>32-34</sup>. In the present study the risk for hypertension was more related to obesity defined by higher WC than higher BMI, as found by other authors<sup>34.</sup></p>
      <p>The prevalence of DM was higher in hypertensive individuals, with an OR of 6.54, which carries an additional burden for cardiovascular disease. It is possible that the endothelial injury promoted by diabetes contributed to the development of hypertension in this population. The prevalence of diabetes in the North-American population is approximately 7%, and 30% of them are unaware of this condition. The prevalence of DM increases with age, reaching 20% in individuals <underline>&gt;</underline>60 years<sup>35</sup>, which was similar to the rate of 22% observed in this age group of the present study (data not informed).</p>
      <p>Urinary sodium excretion had a positive and significant correlation with blood pressure levels in all age groups. These findings, infrequently described in hypertension prevalence studies, indicate a positive relationship among the salt consumption, urinary sodium excretion and the prevalence of hypertension<sup>36,37</sup>.</p>
      <p>Renal dysfunction, evaluated by creatinine clearance &lt; 60/ml/min, was more prevalent among hypertensive individuals. In fact, hypertensive individuals had a 4.5-times greater risk of renal impairment, especially after 50 years of age. This finding suggests a possible association between hypertension and renal impairment regardless of age. </p>
      <p>Population studies have shown different degrees of hypertension awareness by hypertensive individuals. In European countries, these levels range from 52.7% in Germany to 70% in Sweden. In North America, the awareness rate is 82.1% in the USA. Blood pressure control rates in the overall hypertensive population also vary. In Europe, rates range from 22.9% in Spain to 37.7% in England. In the present study, the degree of awareness of hypertension was high and similar to those found by the NHANES study. Among treated hypertensive individuals in this study, about half had blood pressure controlled and about 30%% of the overall hypertensive patients had blood pressure controlled. These data are also similar to those of NHANES 2003-2004, which showed that age-adjusted control rates were 63.9% for treated hypertensive individuals and 33.1% for the overall hypertensive patients<sup>25</sup>. These favorable results are probably due to adequate public information about the disease, investment in the training of health professionals, participation of multidisciplinary teams in the local health system, availability of free government-supplied anti-hypertensive drugs and more aggressive policies at the primary care level, as observed in other developing countries<sup>38</sup>.</p>
      <p>Some limitations of the present study should be mentioned. First of all, the guidelines of the American Diabetes Association recommend the confirmation of hyperglycemia through a second blood glucose measurement, which was not performed in this study. On the other hand, the epidemiological studies, among them NHANES, use almost exclusively a single blood glucose measurement for the diagnosis of DM. Second, salt consumption was based on a single sodium excretion measurement, which is also true for the glomerular filtration rate evaluation by a single creatinine clearance measurement. In this study, we did not assess the lipid profile, a fact that did not allow us to evaluate the dimensions of the metabolic changes associated to high blood pressure.</p>
      <p>On the other hand, this population-based, age-stratified study, with a normotensive control group, is unique by gathering different demographic, epidemiologic and risk factors involved in the genesis of hypertension and of CVD in a single sample assessment with a population calculation, which might be extrapolated to other hypertensive populations.</p>
      <p>
        <bold>Acknowledgements</bold>
      </p>
      <p>We are grateful to Livia C. Burdmann for the careful grammar review of the manuscript. We also would like to thanks Carla G. R. Carvalho, Lina Galli and Rosemara S. Machado for helping with the interviews. Finally, we appreciate the secretarial help of Elisabeth R. R. Zago and Fernanda R. Campos. Dr. Emmanuel A. Burdmann is partially supported by grants from CNPq (National Council for Scientific and Technological Development, Brazil).</p>
      <p>
        <bold>Potential Conflict of Interest</bold>
      </p>
      <p>No potential conflict of interest relevant to this article was reported.</p>
      <p>
        <bold>Sources of Funding</bold>
      </p>
      <p>There were no external funding sources for this study.</p>
      <p>
        <bold>Study Association</bold>
      </p>
      <p>This study is not associated with any post-graduation program.</p>
      <p>
        <bold>References</bold>
      </p>
    </body>
  </sub-article>
</article>
